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ABSTRACT
This research examines barriers to the provision of genetic services I"rom thepcrspectivcs
of gcnetics prokssionals working in the province of Newtoundland and Labrador,
Canada. Based on open-ended and semi·structured key intormant interviews. the study
assesses the structure and capacity of the Provincial Genetic Services Program, the
rclcrral process and protocols tollowed. and the social, historical, and cultural 1~lctors
shaping the utilization of genetic services ti'omthe perspectives of those who provide the
services. The thesis reports on the Ii.lctors that support the usc of genetic services and
t~lctorS that deter or decrease this usc. It identilies strategies lor overcoming challenges to
access to and uptake of genetic services. The key lindings arc incorporated into
recommendations to help define areas and directions tor improvements in clinical
genetics and to provide advice tilr those who develop and deliver genetic services.
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Chaptcr I: Int.-oduction
One of the promises of genetic n:seareh discovery is to identify the genetic basis
of diseases and, ultimately, to improve health outcomes. In the last few decades, genetics
has rapidly evolved from pure (lab) science into a new clinical discipline in the lield of
health care. Genetic services arc the conduit ttl!' translating new genetic knowledge into
clinical practice: the services help eluciLate the genetic etiology 01" diseases and
determine risk, diagnose single-gene or multi-factorial disorders and oller curative and/or
preventive treatment, including population carrier screening,
The purpose of this study is to report on barriers to access to and uptake of genetic
sen'ices in the Canadian province ofNe'Ntoundland and Labrador. The unique
geography, history and culture of the province [i'ames whether and how genetic services
arc accessed and used. This study examines the current structure and funetionalityof
genetic services in the province of Newfoundland and Labrador (NL) and determines
what I~letors hinder the eftective and efficient delivery of genetic services from the
perspectives of those who dcliver these ,ervices.
1.1 Statc of currcnt knowlcd~c
This study builds on the existing body of knowledge about access to and uptake of
genctic care. That research has attended to the perspectives of individual recipients of
genetic care and has thoroughly investigated issues identitied by clinical genetic clients
(e.g" Turney. 2009: Benkendorf el al.. I<J97: DUll), Bowen, MeTicnnan, Sporleder, &
Burke. 1999; Falcone. :V1cCarlhY-\\"(l(ld..'\ie. Siden)\\ L c 'Van I)cllin. 2011: Lock.
Freeman, Sharples, & Lloyd, 2006; Peterson, Milliron. Lewis. Goold. & Merajver. 2(02).
That research ineludes examinations ofelient perceptions and altitudes to hereditary risk
and predictive genetic testing (e.g., d'Agincourt-Canning, 2005; Cooke & French, 200~;
Dahodwala et aI., 2007; Calsbeek et aI., 2007), the impact of genetic testing on
psychosocial well-being (e.g., Graceffa et aI., 2009; Edge, 200~; Vadaparampil, Miree.
Wilson. & Jacobsen. 2006) and the complexities surrounding decision making about
genetic testing (e.g., Cox & McKell in, 19(9). Research with elient recipients of genetic
services has also examined intra-f~lIl1ilial experiences of genetic risk in relation to
perceived and actual kinship tics, illustrating how the flow of genetic risk inflJrll1ation
among relatives has a profound intluenee on, and is shaped by, by tllmily structures and
tlllllily dynamics (e.g.. Forrest ct al.. 2003; Gal"t~ Collins. Symes, & Halliday. 20(5).
Findings ofelient-based research have been used to make recommendations tllr
improving genctie service provision. For example, Skirton, Parsons, & Ewings (:~005)
developed the IIII(/ir Juollor Generic Services, aimed at improving the outcomes or
gcnetic scrvices. Beene-Harris, Wang &: Bach (2007), in their call til!' attention to the
inequalities in access to genetic services. suggested the need for proactive and novel
approaches to achieving improved and effective genetic care (sec also Ilawkins &
I layden, 2011).
Rescarch on public attitudes toward gcnetie testing has also shaped the cxisting
knowledgcabout acccss to and uptakc of genetic services. Researchers havedocumcnted
a lack of public awareness about genctic serecning and testing (McClaren. Delatycki.
Collins, Metcalte & Aitke, 2008; Jonas~.aint et aI., 20 I0). That lack of awarencss has
been attributed to ddicits in the general knowledge about and understanding of basic
human genetics (Christianson et aI., 2010). Although members of the public have
improved their interest and knowledge of genetics over the past decades (in part due to
media attention surrounding the Human Genome Projeet) misunderstandings about
genetics persist in many developed countries including the S (US National Sciencc
Goard, 2008), Australia (Moister, Charles, Samanck, & O'Lcary, 2009). and thc K
(Voss, 2000).
A number of studies have related theehallenges with uptake of genetic serviccs to
a lack of dkctive knowledge communication by primary health care providers and
mcdical specialists (e.g., Geller et aI., 1998; Greendale & Pyeritz, 2001; Rich et aI.,
200~). Physicians' knowledge deticiencics in genetics (Startield et aI., 2002, Kegley
20(3), concerns about time and cost ti.lr discussing genetics with patients (Watson,
Shick Ie, Qureshi, Emery, & Austoker, I()99) and perceptions about the relevance of
genetics in their practice (Mountcastle-Shah & Holzman, 2000) arc reported to contribute
to the low rate of patient referrals tor genetic counselling or testing (Watson, Austoker,
& Lucassen, 2001).
There has been very little research on the eflectiveness of genetic services from
the perspectives of those who provide th,~ services; yct their observations and attitudes
arc key to identifying barriers, both systC'm- and client-related. While, there is an
important body of literature focusing on the perspcctives of genetic counscllors, that
resean;h emphasises the challenges of the genetic counselling process. including
dilemmas around professional obligations to members of the same bmily (e.g., Chan-
Smutko, Patd, Shannon, & Ryan, 2008) and strategies tor disdosing genetic test results
to patients (e.g., Wham et aI., 2(10). Missing is research examining the challenges
inherent within the system, ti'om the perspectives of those who arc the front-line care
providers.
This study is unique in that it I()cuseson the perspectives ofgendic professionals
who are the ti'ont-line providers of genelic int(mnation and services to patients and
dients l . Their viewpoints provide important insights into the barriers to accessing
genetic services and into the radors that shape those barriers. Their perspectives are key
to understanding the range of ways in which genetic eare is understood, practiced.
accessed, used or dismissed altogether.
This thesis reports on the t~ldors that support the use of genetic services and
factors that dcter or decrease this use, in the context of the broader geographic, economic
and cultural context of the province ofi\ewtoundland and Labrador. The genetic
professionals who participated in this study discuss the successes of the Ncwtoundland
and Labrador Provincial Medical Genetics Program (PMGP),2 as well as the barriers to
accessing and using the clinical services offered through the program. Their perspectives
provide valuable intormation ubout hOl~ to eflectivcly trunslutc gcnctic reseureh into
genetic care und ultimately into improved health outcomes. In the context of publiely
funded genetic reseurch und genetic services, this translation piece is umeasurc ofreturIl
on public investments.
This study ulso aims at suggestirg strategies tor overcoming the challenges
identitied by genetic professionals. It offers recommendations that help define urcas and
directions tor improvements in clinicul genetics, The reeommendutions are designcd to
inl<JrI11 policy and other genetics-related regulatory developments at rcgional. provincial,
and nutionallevels.
In this Chapter, I present detailed background intormation on the context and
rationale tor this study. I exumine national, regional. and local milieus and explain how
this study is relevant to the current state of genetic service provision in the province und
how it has the potential to int<lrIll future trends and developments. Chapter:2 describes
my methodology. In Chapters 3 and 4, I present a synthesis of the participants' responses
and I discuss my tindings, which fall into the two broud categories: systemic and
psychosocial barriers. I devote Chapter:' to a synthesis and discussion of my core
lindings und I provide comments on the limitations of my study. In the same chapter. I
provide recommendations ti.H future research needs us well as I<)rsystem and policy
Improvements.
1.2 Back~I'ollnd
1.2.1 The I-Illman Cenome Project (I-ICP). In the past three decades, rapid
advances in human genetics and genetic technologies have brought about the promise or
an improved understanding of~ as well as better management of human health and human
disease. The increased possibility of enhanced health outcomes through genetic
knowledge in the I980s gave rise to the HGP - a symbolic and practical center or
research activity to generate clinically signilicant knowledge to improve health. The IIGP
began formally in 1990 and was intended as a IS-year effort coordinated by the U.S.
Department of Energy and the National Institutes of Health (U.S. Department or Energy,
2(11). The Project aimed to identify all genes in the human genome (approximatcly
20,SOO human genes) and the sequences of the 3 billion chemical base pairs that comprise
the human DI A3 (National Human Gen'Jme Research Institute, 20 II). The initiative was
!lJllowed by an explosion of technological advances, sparking the need tlJr a parallel line
of inquiry into the potential ethical, legctl, and social implications (ELSI)~ of the new
genetic technologies, the information be' ng produced. and the usc (and non-usc) or
resulting genetic knowledge and clinical services. My study is part of that broader
endeavor.
\ I"h~ IIGP w<lscompklcd in200J
/.2././ Cal/adial/ cOl/text. At IcLst 18 countries participated in the HGr and
established national human gcnomc rcsearch programs. Among thosc countries, Canada
established itsclf as a Icader in gcnomic~; rcscarch. The country has becn recognized as
having outstanding discovery potential as wcll as highly regard cd genomics research
facilities and scientists.' Canada's succc.;s can, to a large extent, be credited to Genome
Canada, a non-protit organization establ ishcd in early 2000 to dcvelop and implement a
national strategy tor supporting comprer.ensive genomics research projects benelicial to
all Canadians. Thesc projects covcrstratcgic arcas such asagriculturc, cnvironmcnt,
lisheries, torcstry, health and new technology developmcnt. Gcnomc Canada was given
a mandatc by thc Canadian Govcrnmcnt to be a primary funding and intormation
rcsourcc tor human genomc rcscarch with governmcnt funds allocated accordingly. The
organization has cultivatcd a network of outstanding genetic scientists and rcsearchers.
From the outset, Genome Canada had adoptcd thrce novcl approaches to supporting
rcsearch: it rcquircd co-fundingofprojccts with both domcstie and intcrnational
partners; it cstablishcd regional tocal pointsofexpcrtisc in genomics rcsearch across
Canada; and it rcquired the inclusion ofrescarch into the cthical, environmental.
economic. legal and social (GE'lS) aspects and potcntial implications of the scientitic
research. 6
aglohaltransliJrmatiotl,ln(;e}f(}/}/{'Cwwc!a
\\'\\'w,gcnomccanada.c:ac..'11gc3IsaboUI
Thl:rl: arl: six Canadian genome cl:ntl:rs, situated in British Columbia. Albl:rta. thl:
Prairies, Ontario, QUl:bl:l:, and Atlantic Canada. Thl:se l:l:ntl:rs attrad nl:W researchl:rs
and support rl:search activitil:s utilizing new approaches and tl:chnologil:s. Thesl: hubs are
also conducive to rl:gional projl:ct develnpml:nt that rdkds thl: spl:l:itic needs ofa givl:n
area. Genome Atlantil: is one of the six regional gl:nome Cl:ntl:rs and encompasses all tlwr
Atlantil: Provinces. It is dl:dil:atl:d to building gl:nomics invl:slment and economic growth
in Atlantic Canada.
1.2.1.2 Newlll/lllt1lal/{l al/tl Labratlor cOl/text. In rl:cent yl:ars, the provincl: of
Nl:wtllLlIldland and Labrador7, has bl:come a "hot spot" I'l)r gl:nl:lic rl:seareh. This
hl:ightl:ned interest is due in part to the willingness of residents to participate in scil:ntilic
research (Atkinson, 2000; Greenwood, 2000; Industry Canada, 2002, 104), but primarily
to the high incidence of hereditary conditions, such as cardiovascular disease. diabetes.
obesity and psoriasis (Atkinson, 2000; Taubes, 2(01). The rl:gion's uniqul: geography
and history arl: responsible tl)r the high incidence ofthl:se conditions and their gl:ndil:
unlkrpinning. The I L population of 51 O.oOOx is tor the most part dl:sl:l:nlkd from thl:
original 20 to 30,000 tlJUnders !i'om England (-l6'Xl) and Ireland (-l8%) that had arrivl:d
bdl)re 1830 (Bear l:t aI., 1(87). As tish Wl:re pkntiful, thl: inslwre lishery was the primary
ml:ans oflivclihoocl. Consl:l\ul:ntly, small settkments known as oulports gradually
(http W\\·\'I'.stats.go\·.nl.c,,, Statistics l'olllllatio,1;I"DF Pop!\~;cScx
appeared along the coastline around natural harbours.') Family sizes tended to be large
and. hecause of geographic isolation and religious segregation (English Protestant/lrish
Catholic). multiple distinct gem:tic isolates cropped up on the island of 'ewloundland.
Genetic relatedness and genetic isolation arc suspected in the number of localized
conccntrations of inherited discases (Bear et a!., 1987). In comparison with other li.lul1t!l:r
populations, in Newloundland the launder population is relatively recent and comprised
ofa very limited number of launders (RJhman et a!., 2(03). This may explain why
nowhere else in the country, including the other Atlantic Provinces, is the launder
population as ethnically homogeneous alld geographically stable as it is in this province.
The Ii.lllllder effect, characterized by a decrease in genetic diversity resulting in genetic
drift, has been identilied Ii))" many genetic diseases. The local population displays an
elevated prevalence of genetic disorders as well as elevated carrier tj'equencies, which
makes this province a particularlyattraclive place Ii)!" genetic research. As well. detailed
and rccorded inlormation on the genealogical history of the local 1~lmilies (typically of
large size and closely knit) is readily aVililable or can be easily assembled. The
emergencc of Newklllndiand as a "hot spot" lor genetic research lVas hased on the
contention that such a lVell-documented homogenous pool makes it "easier for
researchcrs to identify the genes associated lVith specilic diseases" (Industry Canada,
2002, p. 103). Recognizing the substanti.,i1 potential of the province as a suitahle place I(lr
gene discovery, Genome Canada and Genome Atlantic co-fundcd genetic research in
ewtiJLJndland through the Atlantic Medical Genetics and Genomics Initiative
1.2.1.3 Atlal/tic Medical Gel/etics al/d Gel/omic.\·ll/itiative. AMGGlwas a
uniquc project that aimed to systcmatically identify gencs and genetic mutations
underlying lilmilial, monogenic disorders in the Atlantic region of Canada. One major
aspect of the initiative, apart tj'om disea~e gene discovery, was to transler research results
from molecular genetic discovery to clinical diagnostic laboratories. Another important
aspect of AMGGI was to study the potential impact of genetic advancements on the
provision of health care services - in other words. to examine the socio-economic
benetits of the AMGGI research. The main AMGGI research sites were at Memorial
niversityof ewtoundland in St. John·s. I L and Dalhousie University in HalihlX. Nova
Scotia. The AMGGI project led to a number ofsigniticant novel discoveries. among
them, the gene mutation associated with sudden cardiac death (Arrhythmogenic right
ventricular cardiomyopathy [ARVel), the gene causing rare anemia (Congenital
sideroblastic anemia) as well as the gene tor ataxia (Sensorineural ataxia) and the gene
lilr a rare genetic eye disorder (Schnyder crystalline corneal dystrophy) II
1.2.1.4. Gel/omin al/d its Etl,ical, EI/vil'illlmel/tal, Ecol/omic, Legal al/d Social
Aspects (CE'LS). An integral component of the AMGGI projeetwas the innovative
"' (;CIlOIllC Callada (Il.d.). i\llallticMcdicaICicllcticalld(jcllolllicslllitialivc
J{ctric\'cdlrolll
http: www.gcllolllccallada.calllcdias/pdllcll;i\tlalllicMcdicaIGcllclio\lldGcllolllicsllliliati\·c.pdr
http \\'\V\\'.gcll()lllcallaI1lic.ca l;)roic'~ls vicw 2-
i\llalllic
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study of the potential impacts of genetic discovery on the provision of health care
services, including assessing the wellbeing of patients and families who are affected by
genetic conditions and who are the most likely consumers of new genetic technologies.
An inter-disciplinary GE]LS team was LJrmed to systematically evaluate existing and
potential genetic screening programs in Atlantic Canada with a view to "facilitate
elkctive and efticient uptake of genetic services". Utilizing qualitative methods, the aim
was to analyze the range of social, bistorical, cultural and economic barriers to access and
use of genetic services b'om the perspeclivesofpatients, physicians, communities, and
policy makers. The GE]LS team was ta~;ked with examining the values, beliefs and
practices of physicians and genetic counselors who arc the providers of genetic services,
as well as those of patients, families and communities to whom these services arc offered.
This included assessing the genetic burden of disease at a variety of levels (personal,
community, provincial, federal), along a number of dimensions (ethical, legal,
psychological, sociological, and economic), in a well-detined population. The idea
bchind the GE]LS component was that a strong collaboration between GEJLS
researchers, scientists and clinical investigators would ensure that thc translation of
genetic research b'om lab to clinical practice to health policy would be etTective.l~
12 Atlantic Medical Genetics and Genomics Initi,llive (n.d.). Retrieved b'OI11
http://www.med.mun.ca/amggi/default.htm
1.3 Rclcvancc oft'cscarch
My study is one aspl:l:t of the GE-1LS subprojl:d and it was supported in part by
funding [i'om thc AMGGI projl:l:t. Therc:torc, thl: rationale for my rl:sl:arl:h l:annot bl:
separatl:d [i-om thl: rationalc of the largl:1" AMGGI/GE3LS agcnda_ From thl: OlltSl:t of this
pl"ojel:l. ll:ontinllously sought int(lrmation pl:rtaining to relatcd GE3LS/AMGGI
tkvdopments_ Undl:rstanding thl: broader contcxt of the initiativl: providl:d ml: with the
nCl:essary insight to engage gendil:s providers in ml:aningful diseussions_ Myown
intellectual and pcrsonal agenda as a res.:archer in l:ommunity health was to l:xaminl: the
sOl:ial, historil:al, l:ultural and economic barriers to al:eess to and usc of gendil: sl:rvil:l:s
Ii-om the perspectives ofservil:l: provitk:s_
My study tllcuses on what genetic servil:l: protessionals (GSPs)1.1 perceive as
dient l:halknges in access to and uptake of genl:tie servil:l:s. This Illl:US on the
pl:rspectivl:s ofGSPs, who havl: both insight into USl:r pl:rspectives and oVl:rsight ofthl:
syStUll in general, provides: (I) tkseriptive accounts of the range and typl:S ofbarril:rs to
aCl:l:ss to and uptakl: of genetic sl:rvices, as well as thc social, l:conomic and politil:al
contl::<ts shaping those barriers: and (2) insights into how and why potential rl:cipients
Illay decline or ignore genetic services ir ways that do not partinilariy retkct "barril:rs"
m "challenges" but rather inappropriateness or irrelevance of the services themselves, to
particular individuals.
In the following chapters, I report on what I learned li'om the GSPs I interviewed,
about the structure and capacity of the Provincial Gcnetie Services Program, the referral
process and protocols followed, and the social, historical. and cultural factors shapinglhe
utilization of genetic services. I begin, ill Chapter 2, with a description of the qualitative
method I used to conduct Illy inquiry.
Chapter 2: i\lethod
This study is based on open-ended semi-structured interviews with genetic service
providers in the province of Newlllllndiand and Labrador. The intent of using this
qualitative approach was to elicit genetics professionals' perspectives on the challenges
to access to and uptake of genetic services. Due to the close-knit nature of professional
relationships in the province and the sensitivity of personal genetic inlorl11ation,
individual interviews, rather than focus groups, were chosen. This approach I~leilitated
open and honest discussion about challenges to acccssing and using genetic services.
while l11aintaining conlidentiality and ol::jectivity.
2.1 Recntitment of genetic p.-ofessionals
For the purposes of this research. I understood "genetic professional"to
encompass the range of health proICssionals with special training in genetics who provide
li'ont-line genetic services to patients/c1icnts '4 and their hll11ilies. In the province of
NcwlilLlIldland and Labrador, at thc time of my research, these front-line providers of
genctic inliJrlnation and scrvices included medical geneticists. genetic counselors, genetic
nurses. and clinical genetic researchers. Through informal discussions with I11cmbcrsof
the various genetic service proICssions aI. the time of designing thc study, 1 was able to
asccrtain that there were 13 individuals who lit the criteriaof"genctic professional" Iill'
the purposes of my research.
These genetic professionals represent a broad rangeoftypesofexpel1ise and
ficlds of specialization. In Newfoundland and Labrador, genetic testing is oflcred Illr a
wide range of conditions that aftcct not 11Illy individuals but families and communities.
The hereditary conditions that are comlronly tested lor in the province include those that
were the object of the AMGGI study ~ ARVC (see p. 8). colorectal cancer and hereditary
hearing impairment. Most genetic profc~;sionalsare aniliated with the teaching hospital at
Memorial University of Newfoundland and clustered in the Eastern Health region
encompassing St. John's and surrounding area. 15 Medical geneticists arc typically MDs
who have completed training in medical genetics and arc certified by the Canadian
College of Medical Geneticists (CCMG). They are direetly involved in cases where a
patient diagnosis needs to be established. Genetic counselors have master's level training
in genetic counseling and are certilied b'l the Canadian Association of Genetic
Counsclors (CAGC) to practice. They provide information to patients on the inheritance
of illnesses and risk occurrence: address the concerns of patients, their f:l1nilies, and their
health care providers; and support paticnts and their t:tmilies dealing with these illnesses.
Gcnetic nurses arc registered nurscsor nlaster's levclnurses with specialized training in
human geneties. Patients may be seen independently by a gcnetic counsclor or genetic
nurse unless a diagnosis needs to be esta·)lished.
Also considered and included asnformants Illr this study as part of the category
"genetic professionals" were clinical genetic researchers. Although researchcrs do not
Illl"l1lally provide genetic services, in the Ncwfoundland and Labrador context at the time
t ~ Set: Figure ~ on page 2R
of my research they wereot!el1 the initial contaet that patients had with the system.
Clinical genetic researchers in Newti.llilldland and Labrador have a rich and extensive
experience studying and mapping genetic aberrations in the local communities. They
serve as a conduit Ii.lr translating research information to the clinical genetics program.
The emphasis in the recruitment process was placed on capturing the lull range of types
of genetic professionals providing genetic services to patients. Therefore, a purposive
sampling strategy was used. As the goal was to obtain information-rich data from as
many diverse sources as possible, the study was not limited to interviewing only genetics
professionals who diagnose patients with genetic conditions. The inquiry took account of
all genetic professionals who provide genetic services to patients and their tillnilies. This
approach was in line with reasoning by Patton (1990), who insists that "the logic and
power" behind purposeful selection of inlonnants is that a sample should be
"inti.>rmation-rich" (p. 169).
The intention of the recruitment strategy was to engage between 7-12 genetic
protessionals out of all thirteen genetic providers (including the PMGP Manager) from all
existing genetic services sites across the province. Thus, a maximum possible
representation li'om both urban and rural locales as well as ti'om diverse groups of genetic
proi"Cssionals was attained. Eleven genetic protessionals ti'omthe province were invited
via e-mail to participate in this study.'f'Table I (sec page 17) provides additional
quantitative inl"ormation about the interviewees.
I<'Pkaserdcrloi\ppelldixi\: tll\'ilaliolllo Parlicipaleill ResearchSludy
Tahle I: Participant Profiles (N=II)
Age Gender Yeal'sof Years of
(in)'ears) Experience Pnlctice
in Role in
Newfoundland
20-30 Female 1-5 1-5
30-40 Female 1-5 1-5
30-40 Female 1-5 1-5
40-50 Female 1-5 1-5
30-40 Female More than 5 More than 5
40-50 Female More than 5 More than 5
40-50 Female More than 5 More than 5
40-50 Female More than 5 More than 5
40-50 Female More than 5 More than 5
50-60 Female More than 5 More than 5
50-60 Female More than 5 More than 5
The reason for limiting invitations to II of the total 13 was that I was primarily
interested in the perspectives of those GSPs who had been working with clients with the
genetic conditions covered by the broader AMGGI project: my selection criteria
preferentially excluded those who specialize in prenatal genetic testing.
The initial contact contained a brief description of the study, cthics approval
inflllmation. my role as principal investigator in the research process and my contact
inflJrlnation. Along with the invitation was included a copy of the consent form that had
been approved through the research ethics review process. 17 Each key informant was
invited to an individual interview and W..lS asked to indicate a convenient date, time and
place I'llI' the interview. The invitees were asked to respond via e-mail. The inflJrlnants
were invited to discuss in person and/or in a telephone interview questions about: I)
what genetic services were currently available; 2) the process of referrals and the
protocols for assessment; and 3) challenges to genetic serviccs delivery, including their
perspectives on clients' challenges to ac,:ess to and uptake of genetie services.
2.1.1 Interview scheduling challcngcs. As simple and straightforward as the
recruitment process seemed at the outset, and despite it having been well designed. it
presented challenges. Certainly, it was a major success that all eleven genctic
professionals invited agreed in principle to participate in an interview. However, with
extremely busy schedules and heavy workloads (my lirst insight into how under-
resourced genetic services in the province arc). coordinating participants' availability for
intervicws was a dcmanding task. When multiple attempts to deline a precise date and
lillleweredifticull, I employed strategie:i such as"reminder 10 book" emails and fllllow
up telephone calls. However, the most sllccessful strategy was to tap into the cultural
norms of NewflJLlI1dland - a personal encounter with the invited in the hallways of the
Ilcalth Sciences Centre presented an opportunity for a chat and an impromptu casual
17 I)lca~e rder to Appendix 11: COIl~ellt 1'01'111
reminder to schedule a time and a place for an interview. It was professionally and
ethically challenging to maintain the balance between completing the interviews within a
certain timeti'ame and not being coercive in recruitment (or worse, inadvertently deterring
potential participants with repeated requests). Eleven genetics prolcssionals were invited
and agreed to participate. Of those who participated, one declined to be tape-reeorded-
likcly out of concern lor potential breach of eonlidentiality, although no reason was asked
for or provided.
Recruitment was conlinec!to NcwlllLlndland because of the additional logistical
and linancial complexities associated with conducting research outside the province and
in Labrador. Further, limiting the study to Newfoundland did provide a wide range of
types of genetic services anc! ensured representation of di fkrent types of genetic
conditions, Finally, loeusing on a Ii-ill range ofprovic!ers within one particular province
with its particular geo-socio-historieal 1~letors, rather than doing a broader but inter-
provincial comparison, enabled a more in-depth look at how context shapes perspectives
and decision making around genetic services. This point will be Ii-lrtherdiscussec! in
Chapters 4 and 5
2.2 Data Collection
Individual keyinflJrlllant interviews were the primary source of data collection fl)r
this study, The interviews were conducted over the course of six months and. as noted
above, involved genetic service providers I"rom the province of Newl"llLlndland, including
medical geneticists. genetic counselors. genetic nurses, and clinical gcnctic researchers.
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Seven out of cleven interviews were conducted in person at the Health Sciences Centre in
St. John's. Four interviews were conducted via telephone through the Memorial
University telecontcrence lacility. Telephone interviewing was the most cost elkctive
method of data collection tllr key intllrl11ants located at the satellite IX genetics clinics
across the provinee. Although telephone interviewing dilkrs considerably ti'omthe in-
person version, the text generated by the two mclhods did not reveal signilicant
differences. The same quality and richness of data waseollected ti'om the participants
who had tace-to-face interviews as from those who were teleconferenced. This tinding
conlirmed the conclusion of Sturges & Hanrahan (2004) that when distance is an issue
interviewing by telephone as a data collecting method works well.
Prior to the data collection phase. I had short preliminary discussions with two of
the potential informants. The intent of these encounters was to stimulates01l1e ideas tllr
the study design, in particular, who should be invited to participate, how to approach
potential participants and how to best structure the interview process. I'!
Thetape-recorded,semi-struclurcd interviews lasted approximately one and onc-
hal f hours. At the start of each t~lce-to-t~lce interview, participants were provided two
copies of the consent tlJr111 (Appendix Bt The consent tl1l'l11 was reviewed and
participants were given the opportunity to ask questions and then sign. The signed copy
was rclurned to the investigator and the other was kept by the participants tlJr their
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records. The intormants who were situaled outside St. John's were asked to I~I:X back the
signed consent torm prior to the telephone interview. This procedure allowed time for the
participants to pose questions about the study in advance of the scheduled interview time
and contirmed that the consent process Itlr long-distance intt)l'mants was as rigorous as it
was ttlr those who participated in persor.
The interview protocol consisted of 15 major question guides and probes
(Appendix C). The interviews began with general background questions, including
employment description, years of specialization, approximate number of clients per year,
and referral process employed. These prdiminary questions were It)llowed by an open-
ended, in-depth discussion of barriers to access to and uptake of genetic testing.
Participants were invited to comment further on their beliefs and attitudes with regard to
the process that they themselves tollowed tor ensuring appropriate access to and uptakL:
ofgenL:tie testing. The probing tL:chniques employed promoted a coherL:nt and aL:curate
account of the participants' pL:rspectives. The usc of probing has beL:n t~lvoured in
qualitative hL:alth research (sec tor L:xample. BrittL:n, I<)95; Patton, 2002; Kvale &
Brinkmann. 20(9). At the conclusion ph.Jse of each interview. participants were given the
opportunity to discuss additional issues that they eonsiderL:d I'devant to the study and to
posefurthL:rquL:stions.
2.3 Ethics
Research ethics approvalltlrthis study was granted by thL: !-Iumanlnvestigation
Committee, ML:n1orial University of I L:wt()lIndland. In addition, regional health
authority approval li)r the study was obtained from the Research Proposal Approval
Committee (RPAC) of Eastern Health tilr those participants who were employed by the
Eastern Health Regional Authority in l;wtilUndland. Each interview lile (paper and
audio) was coded to secure thc conlidentiality ofthc information and to guarantee the
anonymity of each intormant. The clectronic version was stored in a password protected
computer tile. Audio tapes, electronic back upand papcrinterview tiles (transcripts) were
stored in a private locked cabinct. Signed consent tilrms were also securely stored in a
locked cabinet separate from the audio and paper tiles.
2.4 Data Analysis
In order to generatc lindings that transtiml1 raw data into new knowlcdge. I
engaged in activc analytic processes thl'llughout all phases of the research. The analysis
phase involved the convolutcd task of discerning mcanings within the data. I\s I wcnt
through the process of analyzing the data, I found, as Thorne (2000) had observed. that
there was no "sense of mystery and magic" in the process. 211 On thl: contrary. ilwas quite
straightlorward. In truth, I mcrcly attcmpted to makc a "convincing analytical claim"
based on what I believed I understood the intormants to mc'lI1.
1\11 intervil:ws werc transcribed in contidence by a proiCssional transcriptionist.
Thl: aVl:rage length of an intervil:w trans,;ript was 18 pages, totalling 163 pages.
Intervil:w transcripts werl:read entirely I(lUrtimcs: tirst, to acquire a broad oVl:rvil:wof
the complete interview data: sel:ond, to idcntify kcy words and phrascs that detinl: thl:
experience described by the interviewee, third, to interpret the meanings and develop key
concepts/categories; and '·inally, when 111) new insights seem to emerge, to organize the
categories into main themes. As well, the transcripts were continuously revicwed to allow
line-tuning of the eategories lor a prccise and complete account of the cxperiences
studied.
During my initial reading of the transcripts, I was able to mentally note a number
of recurring terms such as patient refcrr~ds, geography and operational capacity. In the
second reading, I highlighted those and other key words and phrases. With the
subsequent (third) reading, I started the coding process by penning down emerging
concepts in the margins of the transcripts across from the consequentialword(s) or
phrase(s). Although the labeling of the categories Illrther evolved, this was an important
phase that allowed me to cluster similar concepts under a common caption, that is, to
organize the categories into main themes. The process I employed I(Jllo\\'ed the method
lor interview analysis described by qualitative research authors such as Strauss (1987)
and Smith (2003).
The interview transcripts, once analyzed and organized into themes. revealed
important insights about genetic prolcssi~mtls'opinions on genetic services and
unearthed inl()I'Illation on challenges to accessing and using genetic services. Their
perspectives are presented throughout my results section in quotation marks, and inelude
direct or indirect quotations. The intent was to allow generous room '·01' the participants'
voices to be heard and have their thoughts dominate the text. In order to keep
participants' idcntities conlitkntial, given thc small size ofthc comnlllnity ofgcnctic
profcssionals, only identilication numbc:'sarc used to describe the intcrvicwee; any other
dcscriptors that would normally be uscd to contextualize thc spcakcr (place and typc of
work, role, professional training, profcssional status, anitiation) arc not cmploycd. as
such details would incvitably cxposc the intervicwce. As well, portions of quotcs that
revcal a clinic site or other details that could inadvertently idcntify thc participant havc
bccn omitted. Finally, my own written commentaries have bccn carefully edited to
minimize the risk of participant idcntiticJtion.
The analysis revealed two broad thcmes - systemic and psychosocial barricrs. The
catcgory ofS\'sfelllic Barriers includes a,peets of the current genetic care dclivery that
wcre pcreeivcd as barricrs by the gcnetic providcrs I intcrvicwed. PSl"c/lIJsocial Barriers
arc attributed to the patients' cxperienccs as perccived and intcrpreted by thc
intervicwces. Economic, political, and socio-eultural contcxts shape thesctwo typcs of
barricrs. 21
In thc next two chapters, I discus:; thcthcmcs raiscd by thc int()rmants. Systcmic
Barricrs arc prcsented in Chapter 3, t()llowed by the discussion of Psychosocial Barriers
in Chapter 4. Included in cach themc arc subthemcs retlectinga widc spcctrum ofissucs
and concerns addressed during the interviews. Thegcnctic professionals' pcrspcctivcs
(mainly il/vil'O quotations) lend color and authcnticity to the discussion while creating
I()(;al points for my interprctative commcnts and analysis.
In keeping with the essence oflilerature review, woven into the thematic
n:porting are comparisons and contrasts with previous research. Although the literature
review component was consolidated into a hriefoverview in Chapter I (Introduction),
given the wide range of themes and suh themes debated in this study. the overview of
significant literature is primarily spread throughout the two results chapters and
integrated into each theme-specific discussion f()r more immediate context and critical
Chaptcr 3: Systcmic Barricrs
I usc the term "systemic barriers" to encompass practices or situations in the
current genetic care system which significantly limit or unillirly exclude certain patient
groups tj'om accessing genetic services. These systemic barriers are of course
interconnected: they shape and arc shaped by each other and all arc embedded in the
geographical, economic and political contexts of NewlllLlndland. In this section, however,
I separate them out in an artilieial way in order to explicate each. Although there was a
wide rangc of systemic barriers identified by the gem:tie professionals I interviewed.
there was a consistent and strong common theme -lack of economic resources.
3.1 Barrier # I: Geography
Not surprisingly. geography was emphasized as playing a dominant rol<.; in the
way that health carc services arc allocated and delivered in the province of
NewtllLlIldland and Labrador. Historically, the natural characteristics of the
Newtl)undland and Labrador coastline and the overall ruggedness of the terrain had
dictated the pattern of populating the province (sec Figure I on page 27). Larger
sellicments were tarmed in areas that wcre most easilyaccessiblc. Predictably. the
density of the population in those areas I'ad increased over the years and transll)rmed
speeiticcommunities intogeopolitieal and economie eenters of the province; other, more
remote areas remain hugely under-popullted.
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Source: Based on I alura! Resources Canada lllap22
Figure I: Map - Province of Newfoundland and Labntdot·
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The map (Figure I) clearly illustrates the uneven settlement patterns. In addition
to the unbalanced settlement density. the populace distribution is heavily congregated
around only a few centers. Naturally, the location of health care t~lcilities and expertise
1()llows the demographic and economic clusters.
The Regional Integrated Health Authorities".1 in the province have been
established around those strategic centers. The map (Figure 2 on page2lJ) depicts the
location, boundaries and population ser\ed tor each health region. It also indicates that
the conliguration of the regional health authorities is intended to ensure effcctive
servicing of each region, clustered arour.d the major urban centers.
Nonethcless, local geography. characterized by vast and unevenly populated
territory. contributes to the unequal distribution of health care resources. including human
resources. For example, as 01'2012, there is only one c(;nter lor radiation treatment on the
island portion of the province, located in the capital city ofSt. John's, where close to one
third of the province's population reside:;. This is the situation with most health related
services: even within the most densely populated of the health regions, the Eastern
Ilcalth region servicing St. John's and area. many patients must travcllong hours to
appointments. Since genetic services arc offered as part of the public health care system
(as opposed to privately owned clinics). these services, too, arc subj(;c( to resource
" In 200-1. Ih~ 1-1 ~xisling h~alth boards of N~II'I(llIndlandand Labrador lI'~r~ ~~llIraliz~d into ll11n
R~gionallntcgrated Ikalth Authorities (Ncwfouldland &. Labrador f)epartm~nt of Ikalth and Community
S~I"\'iecs Annual R~porl. 2005. p. 5). The Easter" Regionallkalth Authority is the larg~st ofth~ boards.
s~l"\ing a pnpulation of290.000 (East~rn Ikalth :'<ewfoundland and Labrador. 2(12)
limitations that the geography of the province has shaped. One research participant
summarized:
It is diftieult to access [genetic care and other care] if you arc outside the
St. John's and Avalon Peninsula area. If you live on the Northern
Peninsula, you have to gu to St. Anthony or to Corner 8rook. [#7]
egional Integl"ated
ealth uthorities
J
Fi~ure 2: Map - Re~ional Inte~rated Health Authorities, Newfoundland and
Labrador
The unique geography of the province, characterized by very small and remote
communities located at times several hours away (i'om the nearest urban center, is
challenging tor the delivery of health care. Genetic services arc no exception. The map
(Figure 3, below) shows the location of the PMGP genetic clinics in the province in
relation to the health authorities' catchment regions.
Genetic Clinics
J
.....
LABR~D011
~ G~'''''......t·( SL ".,NENFOUNDLIltJ~"'il<ooI<. ,'t~ I
~J
~ased on 2006 JepartmentofFnarce. Go,ernmenlof Ne'-"foundland Labrador
Figure 3: i\lap - Genetic Clinics, Newfoundland and Lahrador
The main PMGP genetic clinic is situated in St. John's, while satellite24 clinics
have been set up, one in Corner Brook and one in Gander. There is a genetic research
nurse in St. Anthony: however. this position is not associated with the rMGr~'. The
selection ofgenctieclinic sites tlJllowed the same underlying principlecmployed with
regard to the lourhL:alth regions: the nL:cd Il)r aeL:essible and eftieiL:nt hL:alth services.
Map #3 (seL: previous page) illustrates the large and diVL:rse geographic area covered by
L:aeh genetiL: clinic in thL: province. In addition to the permanent satellitegenetiL: lacilitiL:s.
lravd genetic clinics (administered by medical gL:nL:tieists) have been introduced as a
supplementary serviee in these loeales.
The island ofNewfoundland~(, is eharaeterized by indement and ineonsistent
weatherpattcrns tlJl"mostoftheyear: th,;rct(lre. travel genetic clinies are limitcd to two
scssions per year. The eftieieney ofthos,~ elinics is additionally limited by the inability of
clients to tra\'el- poor road eonditions, espeeially during the wintcr season, or lack or
reliable public transportation (linked also to weather and geography) deter elients li'om
consistentlyallendingappointments. Genetie service providers emphasize that tllr
patients living in remote or rural areas, traveling to and tj'omthe nearest genetie elinies
also imposes arduous arrangements, including child or cider eare tlJl" those Ieli at home
ror sh0l1 or extended periods of time. Geography places extra burdens, including
linanL:ial burdens, on most individuals who need to be seen by a genetieist.
'f< rh~ g~n~li~ c1ini~s ar~ ~stablished only onlh~ island portion orlhe prm in~~ or
labrador
I think the biggest issue we have is geography. If we have somebody in
the Northern Peninsula in Trout River with a population of I don't know,
I 12 or whatever it is, to try and get those individuals down to Corner
Brook or Gander for a genetie counseling session is ,·ery. very dinicult.
This means that person who's in Trout River has to spend two or three
hours traveling to the clinic and two or three hours traveling home. [#61
I guess a big barrier is that there are so many people in Newfoundland
who don't live close to St. John's and getting there is a big deal Illr them.
[#2]
Just the distance - that's another barrier. You know. there will be always
people who live 1~lraway. [#1]
The impact of geography on access to genetie services is of course not unique to
the province of NewllJUndland and LabrJdor. For example. in the Canadian context.
d'Agincourt-Canning and colleagues have identitied the same concern tllr rural and
rcmote areas of British Columbia (d' Agincourt-Canning d aI., 200X. p.554)27
My tindings suggl:st that al:l:l:SS to dticient gl:nl:tic care as well as uptakl: ofthl:
sl:rvices in a consistent mannl:r is imml:l1sely intlul:nced by gl:ography. The l:xtl:nt of this
intluenl:e may gradually diminish over the next tCw ckcades due to the prol:ess of
urbanization as well as demographic changes taking place in the province. Meanwhile,
Illrther capacity building of the clinical genetic services across the province is nl:l:ded to
case the burden ofdisl<lI1l:e and travel time on access to genl:tic care.
To sllmmarize, geography is a powerful barrier to access to and uptake of all
health and social snvices, and genetic services are no differl:nl. Geography penneatl:s thl:
range ofchalknges identitied by the resl:arch participants. Although I artilicially
diftcrentiate geography as a ban'in, Ill!' t:larity in discussion, in bd it underlil:s all of the
barriers identitied through the interview:;.
3.2 Ban-iet· # 2: Lack of Family Physidans
fhcprinciplelllllndalillnofthl:publiehc,llthcaresystl:misthalrl:slllircesllillbc
jusllydistrihukd and casilyaccl:ssiblc. In rl:alit\'. hl}\I'l:Il:r. thcrl:arcindil"iduals,lnd
1~II11ilies II hll arl: ullnceessarily cxcluded in a Cllnlext of limitl:d hcalth care resourccs
Insut'licil:nl acel:SS to family physicians I\as cmphasi/n1 by gcnctic proli:ssillilais
as bcing a signilic"'ll barriel" to rcli:rral t.l, and tbl:rcillre aCCl:SS to. gcnctic sCI·liccs.
II \\'lluld bc I~nnily doct,}rs \lho rccognil.c that SCI l:ral mcmbcrs of thc
1~1Il1ily pwb,dlly hal c thc S:ln1C cllndilil}ll. .\nd I cr\, li·cqucntly. I lilld
p:llicnh do 11\'! ha\c a LlIllil y doc!Oranyl11nrc bccause thc dncll.r len Ithc
COlllnlunily!.[,;lj
!\ portion of the population in the province docs not have a family physician,
either by '\;hoiee or by circumstance" (Primary Care Advisory Committee, 200 I, p. 10).
Residents of rural Newt(lunclland and Labrador are more likely not to have a regular
doctor compared to residents of urban areas (Mathews & Edwards, 2004, p. 1(6).
Genetic professionals reported that this is a major barrier to accessing specialty care,
including genetic services, since access is largely achieved through a referral mechanism.
Family physicians arc strategically positioned to connect patients with the needcd health
care expertiseancl service. Ifhunily physicians are not in place, the "orphaned patients"
end up seeing a variety of health care providers, which may result in inconsistent medical
records and disconnected care (Primary Care Advisory Committee. 200 I, p. 10). Because
of the geographic and social isolation associated with physician practices in the remote
areas of the province!X, the turnover rate of medical professionals is consistently high. ro
minimize it, the provincial government has invested in and implemented various
recruitment and retention strategies; however, ensuring their long-term sustainability is
an issue!'). The province is characterized by low birth rate and outmigration and
diminishing economic vitality30 Supplying and retaining physicians in remote and rural
)~ COIllIllunities illlhose areas :lrc scattered and 1)l"tcn a\'cragc :!OO-500 pcnpk
arcas poscs challenges not only in this province (Mathcws, Edwards, & Rourke, 20(7)
but in other Canadian provinccs (d'Agincourt-Canning ct aI., 20(8) as well as in other
developed counties such as Australia (Kamalakanthan & Jackson, 20(8), Norway
(Straume & Shaw, 2010), the USA ( Hawkins & Haydcn, 2011) and worldwide (World
Ilealth Organization, 20 I0).
A related issuc reported by participants was the lack of consistency of family
physicians - that is, even tor paticnts who did have acccss to a 1~II11ily physician, the high
turnovcr rate of physicians can mean th,lt short-term physicians are not sufticiently
inti.JrI11ed about the specitic genetic disordcrs tor which families of the region may be at
risk.
I think one of the dini,~ulties is that there is such a turnover of rural
doctors. Members of the t~lI11ily, you know, have been so pleased to have a
screening protocol and they've taken it to their I~lmily doctor. And then,
the next time they come in ~ six months later - the 1~II11ily doctor is now a
new hllllily doctor. Could they have another copy of the recommendations
I just scnt to thc previous docto!"") So. this turnover of health care
personnel is a difticulty. Duc to thc very nature of genetic diseasl:s, the
dusters tend to he in th,; smaller communitil:s. II' there is a new person
[physician] there, the 1~I:llily members have a difficult time receiving a
good follow-up, and they are thl: onl:S who need a family doctor who
knows what the problem is in their hlillily, but the doctors keep changing.
[#51
Interestingly, the literature on th.~ knowledge delicit of tillllily physicians has
emphasized lack ofsutlicient education in genetics (Prochniak, Martin, Miller, &
Knapke, 2012; Klitzman, 2009); by C()JlI.rast, my research IGund that the greater concern
was the lack of personal knowledge of the htmilies of the given region and of the genetic
diseases,whichcharacterizelheeommunity.
A second concern expressed bygeneticprofessionalswasthepotentialll)l·a lack
of appropriate relerrals by other specialists. RetCrrals to genetic services arc not only
made by tilmily physicians, but arc also made by specialists. For example, if a hlillily
physician relers a patient to an oncology specialist and the oncologist suspects a genetic
mutation, he/she may further refer the patient or hllllily to genetic services.
Well, I think there is a bij; subset of specialists who don't reter. [#31
So in Ncwfoundland, a 1'.1t of times it's the htmily doctors who rder, and
probably less often, it's the specialists. [#2]
While some specialists have expt;rience with relerring patients to genetic scrvices,
there remain signiticant problems with the level of knowledge about, as wcll as attitudes
toward, population genetil:s among non-gl:netic medil:al professionals serving rural and
3.2.1 Location of ~cnctic clinics. Al:wrding to the genetil: prokssionals I
interviewed, the way genetic care is situated in the provinl:e results in imbalanced al:l:Css.
For example, as 01'2011 there arc no genetic clinics in Labrador. Patients residing in that
region of the province have to travel to the Corner Brook genetil: site (sec Figure:; on
page 30) at those times when the travel genetic clinic is being held. In order to sec a
medil:al genetil:ist during the twice-yearly gcnetic elinil:s offercd at the Corncr Brook or
Gander site, patients must travel either by ferry and road orhyairand road.
You know. [in terms ot] an;ess to the person who lives 10 hours drive
away -- service is not aV,lilable at the same level to you or I who gct our
appoinlment and walk in to have it done. If you have to have all sCI"\'il:es
equaL al:l:ess should include that t~ll:t that Nl:wttJUndlalltkrs arc spread out
over a huge area. So. the:e has to be some way to equalize this cost to do
the visits. I think this is one thing that has to be worked into how you
deliver services. [#51
This lcngthycommute in inclement and at times unprediclabkweatherl:onditions
is not always a feasible or sensible optiol1 tor patients living in rural and remote areas.\[
Clients l:ategorized as semi-urgent or urgent typically need to travel long distanl:es and
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li'equently, whether to the genetic site servicing their area (with choices ofsehedule
limited to times of the medical genetiei~t'svisit) or to the central site in 5t. John's. That
is why the participants IClt that "there's not equal access to everyhody I()J" genetic
consults and care." [#8]
Presently, a permanent elinic in Labrador seems unlikely to be feasihle because,
as research participants explained, the number of geneties professionals in the province is
limited and their workload isquite sizable. This means that even ifresourees were
available t(lI'infrastructural support to sd upa clinic in Labrador, there arc insullieient
personnel.
Concerned about the unbalaneec. access to their services, the genetic professionals
interviewed brought I()rward ideas about improved access: establish travel clinics to
Labrador and other remote regions and IIlcrease the number of medical geneticists at the
5t. John's site to a\low more li'equent olltreach elinies. Rdlccting on the issue. one
participant pointed out that. as a start. a reasonable solution would be to have a mobile
l"acility onering genetic services in the Labrador region of the province over the course Df
several days, at least once a year.
I am thinking that for instance, instead of having the people of Labrador
come to us, Illay be we could travel to Labrador. That way, we could do a
elinie in the cOlllmunity. [#9]
Another participant suggested,
It's almost easier if we hid a traveling clinic, you know, and the traveling
clinic would do the Nonhern Peninsula at this point in time and the west
coast at another. [#6]
However, the province remains a place that has "too few people scattered out over
such a huge territory." [#1]
"I am not sure that we're ever going to [tind] a way .. there's always going
to be a scction of the population that's going to drive or spcnd timc getting
in to appointments." [#~]
This observation echocs the tindings ofother researchers (Evans, Whitehead,
Diderichsen, Bhuiya, & Wirth, 2001; Startield, 2006; Hawkins, & Hayden, 2(11)
n.:porting on the inevitability ofuntavorable health outcomes 1(11' certain pockets of
society. especially those residing in rur::.llocales. Given the t~lct that the rural component
compriscs '+2% of the population of 1 e'vloundland and Labrador (Statistics Canada.
2(06), compromised access to health care seems to be the norm rather the exception.
Irreversible trencls toward urbanization ·~ombined with out-ol~province migration have
plagued the rural cOl11munities 01'1 ewtillilldiand and Labrador inl11any ways. and limited
access to health care is increasingly the reality. Retleeting on the challenges of providing
genetic services in rural and remote cOlllmunities, Hawkins & I-Iayden (20!1) labeled
access to genetic care "a major barrier" to the del110eratie distribution of health benclils
effective clinical genetics can bring(p. 107).
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3.2.2 Technological innovation and rural and remote health service delivery.
In an cHart to rel1ledythe imbalanced access to genetic care, an innovative scrvice
delivery method has been instituted-telel1ledicinegencticsessionswith patients I'ro11l
rural and remote areas of the province. For example, genetic consults tll!' clients who
reside in Labrador arc occasionally conducted by telephone. Patients I'rom Labrador
travel only to a designated hospital oftice in Goose Bay (Labrador) where a nurse
1~leilitates the telecommunication sessioll with a medical geneticist in St. John's. Asked to
deseribetheirtclcl1ledieineserviceexperience,onepartieipanteoml1lented:
I wouldn't say it is equal to seeing patients. It's way better ill persoll.
Connection with the patients is a lot more diftieult over the phone. So I
would ddinitely say t~lce to hlee is better: but IlJr financial reasons. we
will do it over the phone. [#1]
Novel technologies such as the L.se oftelemedieine arc a welco11leadvaneement
and, in the context ofelinieal genctics, they bring the promiseol'improved access to
services and better health outcomesJ2 Ironically, the validity of genetic tests and the
sal'etyand effectiveness of new therapies arc improving while access to them remaills
disproportionate.
3.2.3 Accessing clinical care through research. Clinical genetic care in the
province was originally initiated through research and was operated solely on research
money. Currently, the delivery of the sel'viees is fully funded by the province and
available at no charge to clients: however, it remains closely associated with genetic
research activity. Some of the interviewces repot1ed that access to genetic care and
related medical and/or genetic tests arc signiticantly expedited ifclients become part ora
research study. In other words, a genetic research study can facilitate "queue-jumping"
I(lr its research participants. Despite the bct that there arc notoriously long wait lists (and
wait tillles) tor many patients, swili sen'ice is possible I(lr those who access testing as
research subjects, because research (rather than the provincia I medical care plan) pays
lor the testing services and requires timely results in order to meet project deadlines and
justify funding. In fact, one genetic proiCssionalmentioned that tor clients who arc
research subjects there may be no wait time at all to avail of the testing. Similarly,
another respondent eomlllented,
It's probably unhtir. in that people who participate in research studies
generally get the test d'Jne laster. They generally get int(lI'Illation back
t~lster. So, if we need to have a test, like an MRI, done then we will
probably do lhat aner hours. You don't have to wait six or eight Illonths in
queue with everybody else. Our patients will actually have their testing
done a little 1~lster because we're being billed l(lr it and not Mer. And I
onen say 10 people - tind a genetic study, get into it, which is not bir, but.
1#61
It is worth noting that not every individual with a genetic condition is aware of the
existence of genetic research, including the "'bendit" described above. A client may have
a genetic condition that needs attention at a time when no appropriate genetic research is
carried out. Alternatively, a client may rot be willing to participate in a research study. In
other words, expedited access to genetic services through research may oller certain
benetits; however, it is not an option tor everyone.
It was apparent li'om the interviews that despite the customary argument about
ddicient health care resources, timcly, evenexpedited,access to care is achievable if
patients participate in research. A research study with sound funding, which allows the
research subjects to be paid lor participation, can be especially alluring. and participants
may complete a medical procedure (tor which the usual wait time is months, ifnol years)
in a much shorter period of time. Of course, it could be argued that the number of genetic
research participants is insignificant in comparison to the overall nUll1berofthose
requiring genetic testing and that the benetit to the society produced by the genctic
research can justify these practices. Although this practice - encouraging clinic patients
to enter into a research study to expedite-results-may be benclicial tin the researchers
and dclinitely tor some research subject:;, it is a departure Ii'om the principle of universal
andjustaccess to medieal care. MoreO\'Cr, this practice may have crfects that arc worth
monitoring: most obviously, patients may be being coerced into research. Furthermore,
as benclicial and expedient as the practi,;e of research-related entry in the genetic care
system may be, there are some troubling aspects to this practice that were highlighted by
genctic professionals. One participant succinctly summed this up:
Lots of gl:nctic stuff goes on as part of rl:sl:arch projl:ds that dOl:s not
provide right l:linicaIGln; tor the paticnts. [#7.1
This gl:nctic professional l:xplained that OIKe patil:nts arl: Sl:l:n Ilx the purposes ofa
rl:Seardl study, they may become tlJrgotten. Thc gl:netil: l:ondition, however, rl:mains
with thl: individual or the bmily and nl:eds to continue to be addlTssl:d beyond the
l:ompktion of the rl:Sl:ardl study. In ordcr to till in thl: gap in dinil:al l:are, the patil:nt
must Sl:CUIT a gl:netil: sl:rviee that is able to pil:k up thosl: dil:nts and ItJllow up with
them.
In contrast to this obsl:rvation, another genl:tic profl:ssional stated that thl: l:ardial:
gl:nctil: dinic, whil:h has bl:en l:reated a:; a result of gl:nctil: rl:search, provitks tlJllow up
l:are to all cardiac patients rl:gardless of the way thl:Y havl: accl:ssl:d the system - through
gl:netie resl:arch, or through the convl:ntional rdcrralmechanism by family physician or
medical specialist. This comprdlensive gl:netil: care however is not available to thosl:
with other genl:ticconditions.
One rl:spontknt highlighted the mechanil:s ofl:nrolling patients in l:linical gl:nctic
rl:sl:arch:
If thl:re is nothing dSl: available dinically, wc scnd it tn reSl:ardl. But
that's not quitl: true. If there is nothing dSl: availabk clinically or ifit is
too expl:nsivl: tl)r our budget to pay ItJr, thl:n we'll nncr thl:m [patil:ntsl
research. Whl:never we assign someone to rl:search gendie tl:sting, Wl: tdl
thl: dil:nt that it's probao)ly going to be about threl: months, but could 1)(;
years or never. Vou know, we never give guarantees with research testing.
[#11
The respondent further explained that usually clinical testing is offered where
there is a gene identitied in the t~unily. However, if a gene is newly identitied or rare and
consequcntly not available in a clinical laboratory, or if available but extremcly
expensive, then testing is arranged through research. Nonethcless, this participant also
noted that "not a very high percentage of their patient population" [If I] is offered this
alTangement.
Echoing her colleague's comments, another participant noted that "research
patients" become well aware that geneti,~ testing via research is the only clinical
alternative they have at that moment. In those cases, the genetic professionals make sure
that their patients fully understand that research testing is likely associated with
undetermined results. This means that although some clients may have queue-jumped to
access genetic services (and even have their genetic test completed) the results of this test
may not be received expeditiously and the wait time can be indelinite. In other words,
while queue jumping via research is an attractive (and olien irresistible) option that can
expedite being seen in genetic clinic and may expedite the testing process (non-genetic
and genetic testing), receiving genetic tcst results is till' li'om swill. Understandably, this
is something frustrating lor patients/clients who had entered the system andjumped the
queue via research participation.
And they [paticnts] know that that's [genetic testing, not treatmen!l the
only option they havc. So it's heller than nothing kind of thing. [#21
Thesc commcnts madc it apparcnt that therc arc some ncgativc effects of blending
rcscarch and clinical care. The genctic s~rvicc providers I spoke with raiscd concerns
about the quality and efticicncy of genetic carc whcn offercd undcr the framcwork of
gcnetic rcsearch. They expresscd concern that thc perccivcd promise of quick acccss to
carc (that is, thequeucjumpingwhichclicntsassumetobea bendit of participating in
rescarch),docs not in bct translate into thccxpeditcd reeeiptofgcnetie test rcsultsor
more efticicnt genetic care in terms oftreatmcnt or cure. On the contrary, the wait Ill!'
results can be tedious and t1'cqucntly incdinitc, as it is dependent on whether or not
appropriatc gcnctic testing methods and tcchniqucs becomeavailablc. In other words,
genctic rcscarch may olTcr a quickeracccss to thcsystcm, hut it docs not always
guarantccquick results.
Sometimcs you havc to wait for thc rcsearch to get better to be ahle to
actually givc thcm [paticnts] rcsults. I ean think of one participant. who I
think I saw lirst in I<)<)g and eight years later we were able to give hcr
detinite result. [#7]
Thesc j-indings support thc view that thc presumed duty to communicate genetic
rescarch results to participants is problematic" (I<.noppers, Joly, Simard, & Durocher.
2(06). The challenge stems from the nalurcofthe human genetic research. as its results
n UI1Ic~s the infj)rmation is reliable and clinically signilicllnt
arc usuallyofunknown or uncertain predictive value. and it is not meant to address the
genetic status or other health issues of individual patients (Bioethics Advisory
Committee. 2(05). The genetic professionals I interviewed noted that those issues arc
addressed in the conscnt proccss, but 'research patients' have various levels of
understanding and expectations concerning their research participation.
Yet another concern with using research as a way to expedite access to testing ti)r
individuals is that research funding is not secure. As with any research, genetic research
is dependent on the availability llffunding, and securing continuous tinancial support li)r
research is not guaranteed. This means that the clinical needs of clients can be met
through research only as long as money is available. Once research funding is utilized,
clients who have been enrolled in a study may be "Ien in the lurch" [#7], waiting li)r
years to receive genetic test results. When asked ifpatients who waited tin a long time
Illi' genetic test results received any treatmcnt or other services in the span of those years,
this respondent [#71 explained that those patients continued to have regular clinical
appointments, but those appointments are mcrely to kecp communication going while
awaiting results. a li'ustrating experil:nl:e tiJr patients/clients. Thl: genetic professional
then took the opportunity to argue ti)r the importance of blending clinical pral:tiee with
research:
That is why the research has to link with clinical [carel. because if you
Wl:re doing research per se and it wasn't anchored with clinical Icarel.
those patients would be sitting out there tor eight years not knowing. They
may be affected. You just don't know because you did not have the right
results. Vou could not work it out. Vou can't kave people out there
worrying that they might have it [a ddcetive g(;l1e] because the lab can't
decide because of just the way the testing is. Vou have to provide
sOlllething. [#7]
This exalllpk was provided by the participant to highlight the importance of
communicating clinically signitieant IT>eareh results to dients. Ilowever. the exampk
also suggests that Illueh of that wmillunieationmay entail regularly bringing patients into
the clinic to provide them with an update, even when that update is repeatedly on nothing
dsebut inwillpleteresearch results. Blcndingresearchand clinical care may divert
valuabk resources, which can be utilized tor other, Illore pressing cases. Milkr,
Giacomini, Ahern. Robert & de Laat (2008) report similar lindings in the province of
Ontario and further add that eligibility criteria tor participation in research do not always
coincide with dinieal critcria. Potentially, the entry-through-research practice may
inadverkntlytilterout individuals who area clinical priority. Whikit may seem that it
makes sense to link research and dinical care (since that way research knowkdge is
directly translated into dinical practice and issues arising in dinical care can be directly
addressed by research (ilodgkinson et a\., 2DD,)), the observations of some of the gcnetic
processionals contradicted this logic. ScIl1uds et a\., (20()8) argue that the linc betwecn
research and dinical diagnosis is neccs~;arily 'fundamentally blurry' and 'tluid' and
extend this understanding to their patient practice(p. 386; sec also Pullman &
Ilodgkinson,20(6). In arguing for the 'mportance of keeping those boundaries blurry,
however. they distinguish between genetic research findings that arc unquestionably
related to clinical genctie care, those that arc 'possibly genetic care' and those that arc
'ddinitcly research'. My tindings suggest that, in keeping with that distinction. careful
attention must be paid to ensuring that clients themselves arc not inalh'ertently misled by
blurred distinctions bctween genetic testing conducted primarily tix research purposcs
and testing conducted primarily tor the clinical care of the individual being tested. The
concern expressed by genetic protcssionals I interviewed is that patients are using genetic
research asa means to queue-jump and receive expedited clinical care. Patients arc
disappointed when they tind out that there is not detinitive answer about their risk status
or when wait times tor receiving results are undetermined. Still unexplored is the
question of whether the perceived promise of quicker results may in tact be a kind of
implicit coercion to participate in research, a topic that deserves study.
3.3 Barrier # 3: Cost
There is a high cost associated with establishing and operating genetic clinics. Thc PMGP
is no exception, especially given the resource implications of access to rural and remote
cOllllllunities. Importantly, however, the costs to thcpublic hcalth earcsystem of
providing genetic services are not the only tinancial implications of a provincial genetics
program.
J1l~di~in~su~hns C~l11ad;l·S. i,; an iJ1lpOl'lallll(lpi~ Ihatdcs~IY~S (;ardi.ll study. Such an aCCOUIl( is h,,:yollu
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The provision of genetic services requires a signitieant amount of time and
resources. Services arc relatively new and time intensive; they include genetic testing.
genetic screening and genetic counseling (pre- and post-test). In the clinical setting.
genetic tests can help detect gene variations associated with a speeitie disease or
condition. Genetic tests can be performed to validate a suspected diagnosis. Predictive
genetic testing highlights the possibility of future illness or an individual's response to
therapy. It can also be used as a tool to determine the carrier status ofunaffeeted
individuals. indicating whether their children may be at risk. There is a range of costs
associated with genetic care: individual cost, cost to the province, societal cos!. and cost
lilr research and development. Although the literature on cost is limited. there is a
consensus that the delivery of genetic se 'vices requires considerable expense (Lawrence
et al. 200 I; Phillips, Veenstra. Ramsey. ',an Bebber & Sakowski, 200~). While the cost of
genetic testing is high, it is relatively small compared with the other aspects of genetic
care services such as surveillance, prevention and treatment costs (Morgan. Hurley,
Miller & Giacomini. 2003). Cost of providing genetic testing scrvices was a key theme
running through the interviews I conducted.
Financially, genetic testing can only be done through the main site which
hasa budget Illrthis. MCP
"
doesn't necessarily pay Illr it. Vou can't just
bill MCP. It has to come through the St. John's site. So, the test has to be
"1\ICI' iSlhcacronym I(lr teuicalCarc I'lan.lh:lcrlllllscu in Nc\\'l(llinulanuanu LabrauorlOrd\-rlothc
pro\incial ~kdicarcprog.ram
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deemed appropriate. That's why cveryone has to be seen by somcone in
St. John's bctl)re they arc eligible to gct that genetic testing done. [In I
The genetic testing Il)r the cancer gene is extremely cxpensi\·e. It's only
offered through one laboratory in the US, which patcnted thc gcne, so no
other lab can do it. [#1]
It would be eheapcr if lI"e could do thcm [genetic tests] in-house but we
don't have lab resources. We do not have the technologies. Our diagnostic
lab docs genes that arc elJmmonly taken li'OIll our population. At least 50
percent of our molecular genetic test is outsollreed to other Canadian labs.
American or European lel1S, wherever we can get the cheapest test. 1"1181
As mentioned earlier, the PMGP is closely associated with genetic rescareh
aetivities. Otten, the type of genetic testing that is required and the speeilie genes being
tested dictates whether testing in a research setting is possible. The majority or
participants indicated that they have collaborated on a number of research projects carried
out by molecular or clinical genetic researchers. This alliance proves benclieial.
especially when genetic testing may con:;titute part of gene hunting. Thc respondcnts also
commented that although the research-related testing has no immediate clinical benelit to
patients, it could lead to genediseo\'ery. The respondents also commented that thc
process of searching tilr a gene is time consuming and costly. with no guarantee that thcre
will ever be intimnation of clinical relevance coming out of the rescarch. One of the
interviewed genctic professionals indicated,
No genetic service really has enough of time and money and
certainly Newfoundland docs not. [116]
I-Iowcver, when gene hunting is shceessful and the benelits to individuals arc
obvious, then the relationship between re~,earch and clinical carc is valorized and its
importance re-contirmed. 1\ good cxampk is the identitication of the gene causing
I\RVC-,6 Local familics known to carry a mutation are now tested and provided tilllow-
up care, thanks to a succcssful research study,
Thc respondents also explained that once it is established that thcre isa certain
mutation in a particular 1~lInily. it is casy tD test other tinnily members to detcrmine
whcthcrthey have inhcrited thc same mut.ltion or not. This proccss is rciativcly
uncomplicated and not as costly in comparison with cases where the exact mutation in a
lillnily with hereditary conditions is not identitied. Although Icss costly. the latter proccss
still rcquircs significant amount of funding. cspccially long term funding, to sccure its
smooth opcration. Thc genetic professionalscommcntcd that it may take years bctilre a
Illutation is "workcdout.,,·n
" rodaril'y. this is Ihc ICnl1 lIscdbykcyillliJrmall s
As treatment I(lrspeeitie genetic conditions is not always available. genetic
screening and/or testing arc not always cost effective. Petersen, Brensinger, Johnson &
Giardiello (llJ99) discuss the significant cost associated with genetic testing I(Jr
hereditary torms of eolorectal cancer, in particular. They suggest that the cost advantage
1(1I' gene testing increases as the size of the pedigree3X and number of at-risk members
increases. In the casc of colorectal cancer, genetic testing is not relied on tor screening or
diagnostic purposes. I evertheless, it may be considered appropriate lor high risk 1~lIl1i1ies
to establish the possibility for developing certain forms of colorectal cancer.
Genetic testing is labor intensive and rel.juiresexpensivcel.juipment. As well. the
testing has to be appropriate tor the patients who l.jualify. The genetic professionals I
spoke with pointed out that the high cost prevents them from offering timely service to
everyone eligible tor genetic testing:
Due to cost, wedo nothaveaccesstotimelytesting.ltll]
Sometimes the eritcria al'e there. but we have to lind 1~lIl1ilies that will
most benclit from the t~sting. Do you run the risk of missing a I"cw
bmilies'/ Yeah, you probably do, and it's a constant. [tl3]
Although genetic professionals arc vigilant in creating and relining their criteria
Illr testing, they are limited by cost and lacking resources in their practice. These
limitations arc passed on to their eligible e1ients.
We generally sign up people to research projects when there is no clinical
testing available. As we ,;an't buy the test our next best option is to enroll
them in a research project. [#1]
Research labs tend to perform te:;ting tor individual patients when ordered though
a genetic professional. However, a test Illay provide inconclusive results and may require
multiple I~lmily members to participate. In addition, ifgenetic testing is done in the
context of a research study, testing results may not be available Illr many months or
years, and sometimes they do not become available at all.
If we arc trying to lind the mutations in a t~lI11ily and if there is no knl)wn
mutation out there ... we: arc looking tl)r that needle in a haystack, those
are the ones that take the longest. [#6]
Pal1icipants also explaincd that there arc not enough people working in genetic
research labs. due to scarce or inconsistent funding tor searching tllr gene mutations.
Funding is more likely to be available to per!lJrlll tests once a genetic mutation is known.
An important aspect of the cost of genetic services to patients is the cost of
genetic counseling. Genetic professionals invest signiticant time in providing counseling
to clients as part of the pre-test orientatir,n as well as the disclosure of test results. The
professionals I intcrvicwcdcmphasized thc timc consuming naturcofthcir scrvicc. which
includcs triaging, preparation and dclivcry of a consult scssion, communicating gl.:nctic
inl"(JrIl1ation to c1il.:nts, conducting t()lIow up by tclcphoncor in pcrson, and documcnting
thc consults. I hc protCssionals discusscd thc timc and effort involvcd in tailoring
individual counscling scssions to the specitics ofl.:ach case, cvcn t()rcounscling
individuals within thcsamc hlll1i1y.
... you look at the referral and you you'll think - I nl.:l.:d to run alicr this a
bit more and you will call them [the c1icnts] and you'll gl.:t soml.: morc
intormation ovcr the pholle and you'll hand hold a bit morc. [#:11
And so, you just takc any pcrson as thcy I.:omc and try to scc what thl.:ir
lel.:lings arc and try to hclp them. [#2]
These cxcerpts are in line with prcvious tindings demonstrating that providing
imkpth int(JrIl1ation that is spccilic to ea:h prcscnting membcrofa 1"~lIl1i1y is an important
part of the counscling proccss; howevcr it is assol.:iatcd with timcand cost (Pl.:tcrscn ct
al..1(99).
Thcgcnl.:tic protessionals I intcrviewcd also cmphasizcd that [()rsomc gl.:nl.:tic
professionals it is not only thc timc takcn to SI.:C I.:licnts, but also thc timc to travcl to SCI.:
c1il.:nts in rcmotc and rural arcas, which ,idds to thc ovcrall cost of providing gClll.:tic
counscling scrviccs.
In theirquantit:.Itive study, (Lawrence et aI., 2001, p. '+79) demonstrate that
genetic counseling is costly in terms of personnel time. as it averages thrce to '"tllir hours
per client tt)r a counseling session. Their tindings further reveal that this cosl. although
high. is insigni ticant compared to the cosl of genetic testing and disclosing results.
Only one research particip:.Int felt uncertain about the advantages of providing
patients with inttJrlnation about genetics :.Ind genetic care in relation to the overall high
cost of the care. One aspect of the dilemma revolved around the '~Ict that certain diseases.
cancers in particular, arc not always gendic-based. The concern was that the cost
associated with genetic services delivery is consequential, yet an insignilicant percentage
ofelients can bendit ti'om those services. The comments specitically referred to breast
cancer cases seen at the gcnetic clinic.
A genetic condition is only a very. very small part of that whole illness
protile that anyone perS(ln might have. Here's an example: Breast cancer
is only 15 percent ofcarcers that have a genetic reason. Yet. you know.
we don't sec that 15 percent. We might sec, well. I or2pereent.lll.+j
The research participants did not mention anything about the cost related to
patiL:nts who, due to a poor or incomplek prelilllinaryassessment and referral process
(including selt~assessmentand selt~rererral),present themselves at the genetic clinic and
undergo further investigation when not necessary. Although the issue was not brought up
during the interviews, it is worth noting the tindings of Reis et al. (2006), who emphasil.e
thc"substantialcost"associatedparticularlywithlow-riskpatients(lruelow-risk,not
1~t1se) referred for gcnetie consults or screening procedures. These arc classic cases of
"little return" that add up to the already high cost of genetic care.
The genetic protessionals rciter:r:ed that the lack ofadeljUale resourecs infuses
every aspect of their services. They admitted that at times it is a challenge to keep
operations aligned with nationally accepted standards. Although they did not provide
specifics, their commentary is dircct and elear.
I think the problem is that in some cases wc really do not keep up with the
national standards because wc don't h<lve the money. We have a lixed
amount of money in ow budget. So, tlwt's our big thing. It's not not-
knowing what to do. Wc know what to do. Wejust don't h<lve the money.
[#8]
Although providcd at no direct cost to patients, gcnetie services entail signilieant
linaneial sacritiee to individuals and to communities. Oneofthe I'inancial burdens
emph<lsized by genetic protCssion<lls was thesignilie<lnt costsoftransport<ltion and
related costs incurrcd beeausc of the time that transportation entails. Recipients ofgenctie
services. particular thosc living in rur<ll and remote areas. incur signilicant costs related to
transport<ltion.
Somehow that cost of that tlight or that drive or the 1~lct that you arc not
working tor three days - the day you arc driving across the island. the day
you arc having your appointments and day you arc driving back-
something has to eljualil.c things to covcr those aspects. [#5J
Other signitieant costs to paticnts occur whcn commuting to thc ncarcst, yct still
signiticantly distant, gcnetic centre.
It is so expensive with g,s and lodging and they are coming in just to havc
a conversation, right'l So a lot of people don't see that as necessary. [#21
Accommodation is an additional expense ifpatients have no option to stay with
relatives or friends. For the duration 01'<1 visit, eating in restaurants is usually the only
option, and one that is more costly than ,:ating tiJod prepared at home. Very onen paticnts
travel with one or more htmily members or ti'iendswho provide emotional support, which
further increases the out-ot~pocket expenses.
It is not unusual to have a last minute cancellation ofthe genetic consult ifthc
geneticist is sick or, tlJrother untiJreseer reasons, becomes unavailable [ill' the
appointment. This can contribute to further costs for the patient and those who
accompany them. It is, of course, artilicial to separate out the issue of these linancial
costs related to transportation (a systemi: barrier) Ii'om the psycho-social experiences of
individual patients and htmilies bearing lhose costs (to be discussed in Chapter -l).
304 BalTier # .t: Limited Capacity
The primary tiKus of the PMGP .;crvices is to assess and manage patients that
have been referred to genetic care. The program also looks al the strengths and necds of
clients in order to determine other service needs. For instance, l~lIl1i1y needs are addressed
in order to help create an appropriate support environment that enables both elients and
their l~lI11i1y to better cope with possible distress. In some cases. genetic prolCssionals
also relay inl()rmation to the extended Lunily.-;') In dlcet, the genetic care is
individualized (tnilored) in a way that meets the unique needsofelicnts and their
t~lI11ilies. Services arc available in three locations in the province - St. John's. Gander and
Corner Brook (sec Figure 3) - and patients nre given a choice to be seen in the most
convenient location. The three sites, as explained earlier. were set upas permanent
genetic assessment sites (however with \'isiting medical geneticists) in the relatively large
urban centres in the province.
3.4.1 Lack of personnel. At the time of the interviews. there were only two
medical geneticists serving the entire province. Typically. they otkr consultations at the
St. John's site ns well as through satellite (travel) clinies40 The genetic e1inics established
outside St John's lllllow the triaging prolOeols adhered to at the main centre. however.
those clinics "barely meet the demands" as one informant [#4] commented. The satellite
e1inies lack permanent medical geneticists to provide administrative. diagnostic or
supervisory duties on site. Unlike the St. John's site, where the medical geneticists arc
stationed together with a team of genetic counselors, the lack of other permanent staff in
the outreach e1inies makes it cumbersome l(lr the gel1etic nurse-coul1selor41 in the
outreach e1inies: they tj'equently need to eOl1sultwith the 51. John's site. Although
cOl1ll1lunication with thc main sitc occur; rclativcly rcgularly. thc contact is not
iml1lcdiatc and only via tclcphonc~2 As wcll, whcn thc mcdical gcncticists completc an
outrcach visit, thcy routincly takc thc didations from thc consults to St. John's to havc
thcl1l typcd. According to onc participant. thc typing may not bc complctcd right away as
it is addcd to thc alrcady high volumc of papcrwork that is proccsscd in St. John's. This
crcatcs a backlog of paticnt lilcs at thc St. John's sitc that, according to thc participants,
translates into dclays of at Icast six l1lonths. As wcll, all othcr papcrwork is scnt to St.
.John's for approval and thcn I(1I"wardcd back to thc outrcach. Although having thc St.
John's site as a hub ItH' ccntralizcd managcmcnt ofclicnt I'ilcs may bc a scnsiblc approach
in tcrms ofcflicicncy (in 1~let, thcrc is no feasible altcrnative), it does not easc the already
time- and labour-intensive proccssofgenetic care delivery. Because this process of
having patient liles proccsscd in a ccntrallocation is under-resourced, it is burdcnsol1le
and lengthy and thus adds to the wait time lor patients as wcll as to the ()\'erall cost.
Each of the two medical genetici:;ts stationed in St. John's is assigned an outreach
centre. Thcy are scheduled to travel to their assigncd area once or twicc a year to pnl\'ide
scrvicc It1l"two weeks at each clinic. Thi:; presents a very limited window of time ItH'
patients to be secn, and translates into only IXpatients a year according to the
participants. This lil11itcdtil11eli'al11eexposesthegencticoutreachstrucluretoawide
range ofvulncrabilities:
You know, with only tllO geneticists in Newl(lLIndland, if someone gets
sick, then everything l~l1b clown. [IN]
rhePMGPaddressesthosevulncrabilitiesbyattraetinglocums li'omother
provinces. Typically, a locum is a semi-retired medical geneticist who is recruited to
cover the duties of the local medical geneticist when that geneticist is unavailable.
Typically, locums work for three to six weeks per year at the main genetic site. This
practice, initiated relatively recently at the time of the interviews. helps with both casc
managcmcnt and wait times; howevcr it~; scopc is limited, as locums do not have
administrative or supervisory responsibi'ities, and their availability on an as-needed-basis
is not certain. So I~lr, only one locum ha~; had a clinic in the outreach, which lasted I(lr
one wcek. Budgctary and physical space constraints contribute to the decision to attract
locums instated of hiring permanently additional gL:netic professionals.
Given the increased dL:mand lor genetic L:are and the large geographiL: arL:a scrvL:d,
the number of mediL:al genetiL:ists is I~\r li'om adequate. So is thL: number of gL:netic
L:ounselors, espeL:ially outside St. John's. To offset this shortage, nurses with genctiL:
training43 provide counseling servicL:s in the outreaL:h. The iSSUL: of limited availability of
genL:tiL: protCssionals has arisL:n ,KroSS Canada (SilvL:rsidL:s. 200]) as well as in othcr
L:ountriL:s and has beL:n rdkctL:d in prL:vi,.lus studiL:s (Hawkins, & HaydL:n, 2011 Yoon.
Thong. Taib, Yip, & TL:o, 20 II; Klitzman, 200(); Vig L:l aI., 20m).
" rh~ pra~lic~ or hiring g~l1~lic nllrs~s has bl'~l1 .Iiscllss~d by L~c ~l al. (200(')
According to the research participants. thechallcnges associated with insurticient
personnel extend to thegcnetie labs as \\'ell. which compounds the time and workl()rce
constraints associated with genetic care.
In general, the interviews reveakd that whilc the current structure (that is.a
system dependent largely on one central and two satellite/travel genetic clinics) bcilitates
access to genetic care, the outreach modd is hlr !i'om mecting lhe desired standard of
care. Having only two medical geneticists serving the entire province is seen as an
unsatishletory arrangement; however, in,:reasing the number may not be an immediate
solution duelo limited resources. Rdlcctingon the issue. one research participant noted:
So, I think in a perfeet world (pause). we would have unlimiled number of
genetic counsclors and geneticists working in this clinic. I wish we had
more people. Ilhink financial resources arc always an issue. [#:lJ
3A.2 Heavy workload. Dealing with a heavy workload is another issue closcly
related to lhe limited number of genetic professionals in the province. Not surprisingly.
when invited to comment on the barriers to providing genetic care. participants indicated
that heavy workload is an on-going issuc,
We'rerunningprettymulhon full cylinders ... rtn]
One aspeet of the heavy workload bortle by the genetic service providers isthe
cumbersome process of obtaining and re'viewing important (medical and t~lmily related)
inf(ll'll1ation from clients as wcll as documenting that inf(lI'Illation in the appropriate
tlJrlllat. Participants noted that the number of patients they see is not as high as those a
medical specialist or hlmily physician would attend to. However, they cmphasized thl:
oVl:rwhelming amount of labour involved in ddivering gl:nelil: carl:, which more than onl:
partieipantdescribed as a "different stykofmedicine"- genetic prorcssionals are
rl:quirl:d to spl:nd a signiticant amount of time preparing betllre they see a patient and
genetie consultations are consistently lengthy.
Wel:stimatl:c1 that to Sl:l:our patients takes us about eight hours. and that's
cight hours alter a lot of assistance is givl:n in terms of collecting or
rl:vil:wing patient intlJrlllation ... [#X]
A considerable amount of paperwork needs to be assembled Illr both gl:nl:tic
diagnostic and counsding purposes. As t~lIllily history intllrmation is key and the proCl:SS
of attaining it is complex as well as time consuming, thl:re is a (lesignatl:d pnson (on a
rotation basis) at the main PMGP site in St. John's who is responsible I'llr collecting
ml:dical history li'om various sources, induding pl:rsonal and t~lInily ml:dical records.
Based on the t~lI11ily history inllJrlllalion provided~~, a genl:tic counsdor
constructs the patient's pl:digrl:l:.~5 Alth(lugh centralized management~(, ofthl:Sl:
documl:nts is a prudl:nt approach, it dOl:> not lranslatl: into less papl:rwork. On thl:
contrary, thl: workillad is consistently high l:spl:cially at thl: satl:llite clinics:
I" /\( the time of Ih~ intervicws. it was rcporte:d that ~O-3() II u or jk'digr('('s arc drawn by 1I1H.krgradu:llc
:-.tudl'llt\'olulltccrs
If. rhccompklco ramily history qucsliollnaircs arc n.:-cci\cd inSt. John'sunless it isadircct rl'll'ITallolhc
outn:achdillic.
Well,theykindofhavetodoallthatthemseivesintheoutreach,so I think
paper work is probably a little bit more extensive in the lJutreach than it
wouldbeinamajorcentcr.[#lJ]
Each satellite clinic has one permanent genetic nurse/counselor who resides in the
area. Having knowledge about the li.unilies in the community is of professional advantage
to the nurse!counselor in configuring pedigrees and helping clients to lill out lilmily
history lorms. Being part of a particular coml11unity also helps the genetic
nurse/counselor in establishing rapport and trust with clients. While being Iilmiliar with
clients and their relatives li'ol11 the area lilcilitatcs the work of the genetic prulcssionals to
some degree, it takesconsiderablctimeancl d"tiJrI to address theelinical as well as the
emotional needs of each client:
In terl11s of the consult. r,:ading the person's emotions and everything ~\Ild
making that really good personal contact is important. [1/21
The assessments arc a lot longer and liJr a new consult we take an hour
and a halfand we add res:; the needs not just fiJr the person sitting in front.
but those of at least the first-degree relatives, if it's that type of genetic
risk. II/X]
In addition to communicating wilh patients and medical geneticists (in-person, via
telephone or in writing), the genetic counselors arc involved in obtaining pricequotcs
li'om genetic labs. scheduling genetic tests and. in the case of satellite clinics, even
pert()\"1l1ing some preliminary tests.J7 Both medical geneticists and genetic counsellors
also prepare and review a high volume of paperwork preceding and 1()lIowing the genetic
consult. All these activities arc both labour and time intensive. especially when only
limited clerical help is available.
Well, too much paper \\·ork. And probably not enough support. I don't
mean genetic support; but I need, like I said, a person hclping me wilh my
work. [li9]
For the outreach clinics. the work processes arc even more convoluted as access
10 both professional and clerical support is not as immediate as at the St. John's site. For
example. generally uncomplicated proccdures such as approval of correspondence to
patients or typing geneticists' dictations becollle tortuous as the papers arc sent to the
main centre and processed there (depcndingon availabilityofpcrsonncl), and then
mailed back.
The literature on the work of genetic professionals has described well the time-
consuming nature of conveying int(JrIll<lIion about the basics of genetics to patients (sec
especially Yoon et 'II.. 20 I I): Pedigree contiguration, risk assessment. diagnosis.
intcrpretation uftest results, as wcll as l)I"eparing and communicating other relevant
inl()1'Il1ationtoclientstakeadditionaltiIT.e. My research has shown. however, that the
p IIH:S~ arc not gCl1ctil..: tcS(S
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"hiddcn" work of managing paticnt lilcs is cqually signilicant in tcrms oftimc
304.3 Continuity of carc. Carc relatcd to a gcnctic discasc cannot bc providcd by
agcncticistalonc. Mcdical scrviccs 'i.Jrhcrcditaryconditions involvcothcrmcdical
spccialists as well. For cxamplc. in thc C1SC ofhcrcditary colorcctal canccr,
gastrocntcrologists and lor surgcons arc involvcd. During thc intcrvicws. participants
rcportcd that thcrc arc not cnough gastrocntcrologists inthc provincc to pcrt(lI"111
colonoscopics. nor surgcons to carry out intcrvcntion whcn appropriatc.4x Rcscarch
participants commcntcd that coordinatio'] ofcarc is a hugc barricr.
Carc rclatcd to a gcncti ~ discasc is not just by a gcncticist. If it is a
ncurological discasc, thcn your ncurologist and maybc a ncurosurgcon will
bc involvcd. And so, you havc to havc acccss to that part ofgcnctic carc. It
is not just thc gcncticist and gcnctic counsclor; it is what thc gcncticist and
gcnetic counsclors rccommcnd kccping you hcalthy. I think that's thc
thing that somctimcs is cot considcrcd and olicn that can bc a barricr..
Thc pcoplc havc to bc I(lllowcd up. That's what's difticult - to put that
wholc pathway in placc. [#5]
According to this participant, it can bc a challengc to sccurc 1()llow up I()r paticnts, both
by gcnetic profcssionals and othcr spccicilists. As van Maarlc, Stouthard, & Bonscl
"rhi,pointi,"o\,pccilicloco)orcetalcanccr.lrckrtolhi,condilion,pccilicallyl()rillu'lralioll
l)lIrpo~\..'s
(2002) note. strengthening the link betw,xn genetic diagnosis and follow up care is
critical in achieving high quality genetic care.
In contrast. another participant provided an example of successful continuity of
care - a cardiac genetic clinic, which utilizes a multidisciplinary approach and provides a
full range of necessary genetic services, cardiac care and t()lIow up. In the particular
clinic described, patients with a genetically inherited cardiac disorder are ascertained
through geneticresearchorthe PMGP and arc treated by cardiac specialists in
cOlllmunication with their I~lmily physician.
This clinic works extremdy well because it has cardiac services involved,
genetic services involved, genetic research involved, and all the
int(JI'1llation goes to the right physicians who are involved with the
patients, so all bases arc covered. basically. [117]
Part of the problem with providing continuity of care is geography and its
associated barriers, as already discussed. For example, ttl!' patients with ARVC.~') St.
John's is the tertiary centre !()I'cardiac diseases and the only place in the province where
patients can be treated t()rcardiac conditions. Although cardiac patients who reside
l1utside St. John's may be in close proximity to a satellite genetic clinic. the only service
thcy can l1btain at thc outrcach clinic is gcnetic information. For cardiac-rclatcd tcsting,
including gcnetic testing, they have to travel to St. John's. They also have to travel to St.
John's for the treatment itself. Hence, although continuity of care exists in theory, issues
related to geography and its related social and economic costs arc signilicant.
Lee et 'II. (2006) comment that bringing together professional expertise in a
multidisciplinary team is a challenging Llsk in genetic care. This holds true e,·en where
genetic services arc delivered in a publil hospital. Beene-Harris et al. (2007) suggest that
there is an apparent necd lixother health professionals tojoin genetic spccialists in the
provision ofliJllow-up and supportive care: they call liJr improved coordination between
diagnostic and liJllow up care by installing an infrastructure that encompasses all the
necessary health expertise. However, in the Newfoundland and Labrador context. the
issue is not one of lack of engagement of specialists in genetic care: rather, the issue is
how to access the continuity of care that exists. given the challenges nf geography and
limited resources.
In their cnlJlmentaries, the participants openly pninted to the need Illr changes to
the system to transl·iJrm genetic care into more accessible, meaningful. and eflicient
arrangements I'Jrboth patients and providers. The nature of genetic disease is such that
,·isiting the genetic clinic is only the lirst specialty care stop I,ll· patients and tinnily
lJlembers: the genetic e1inics cannot resolve all aspects ofcJre needed. Securing access to
other specialists within the continuum of care is crucial, and this issue demands further
investigation and resolution.
3.4.4 i\lanaging client volume. One research participant in particular elaborated
on the lack ofsurticient rcsourees neecssaryto handlc the volumc ofpeoplc accessing
genetic services. A concern was express~d that raising people's awareness about genetics
may bring more clients to the clinic' and that the clinic docs not have the capacity to deal
with any increase in client volume.
We do not have a lot of time and resources to deal with a lot more rekrrals
eftieiently. So, it becomes one of those things that you're sort of balancing
how aggressivcly you want to go out and lind these other referrals. [In I
One research participant felt that "direct advertising" might be key to improved
public knowledge about genetics and genetic diseases. Ilowever, the participant
expressed concern that this inllJr111ation may generate unnecessary fear about genetic
conditions that people mayor may not Ilant to be screened Illr.
We generate fear. you know, by telling them [the public] that these
conditions exists when in t~lct you know, if you think of illness as a
whole, a genetic condition is only a very, I'ery small part of that whole
illnessprolile.[#'+]
When it comes to promoting geno:rie services, "marketing of kar50" is nol an
acceptable technique: however it could be quite cfkctive in augmenting client volullle.
l3ecauseoffcar Illr their health and the health ol'theiroffspring, people seck genetic
services anel want to be tested. A spike in fear results in escalated demand Il)r genetic
testing, which, in turn. cndorses theestahlishment of services.
So, that's [whether or n'Jt to raise public awareness] always a dikmma.
you know, that I struggle with, because we do not have the resources to
handle, tllr instance, an intlux of patients that we could generate into our
department by just makirg people aware of genetic conditions. l#~ I
The demand-spawlled-by-fear pllenomenon has been well documented in thc
literature since the concept of"geneticization'l .. (Lippman, 1991. p.1 X-19) was lirst
introduced.
3.4.5 'vVait times. The issue ofh,,)w to manage the volumc of patients accessing
the PMGP services is intertwined with both the shortage ofgelll:tie professionals and the
labour and time-intensive workloads they have. The protCssionals I interviewed
distinguished between wait times tor an appointment with a genetic counselor or clinical
gencticist, and wait times to have a genetic test completed. Further, they wcrc of thc
opinion that wait time, especially tllr appointment with a medical gcneticist. is directly
related to the number of geneticists and ;;enctiecounselors. They explained that ira
physician refers a patient Illr genetic assessment. it maytakea year or so belllre that
patient is called tllr a genetic appointment.
The wait list lor medical geneticists right now is Ilwr months to a year and
a half, to see them. [#11
The participants reported that the PMGP has made attempts to address wait times.
For examplc, at the time of my research. the model of client intake had been impn1\'ed by
adopting a centralized triage system based on three priority categories of cases: urgent,
semi-urgent and routine. On a monthly rotation basis, a genetic counselor in St. John's is
assigned to client intake duties and allot:; each case to a category as wcll as to a colleague
according to his/her "'specialization,,'2 Triaging is dependent on diagnostic criteria as
wcll as client age and involves protCssional judgment. One participant stated that clients
could always access the system, but whether their case will be expedited depends entircly
on the category one is triaged to [ItS]. In general, an urgent case is a high risk case that
requires clinical management of the disease; it is processed I~lirly quickly with access to
testing "'in a matter ofa couple of hours to n hours" [#3J. This generally includes in-
patient hospital referrals and unusual metabolic cases. Semi-urgent cases, which most
clients 1~t11 into, arc supposed to take three to six months waiting Illr testing. Such semi-
urgent cases may include instances in which, based on t~lmily history. there is a strong
indication that a t~lmily member may carry a mutation. Non-urgent cases arc rell:rred to
as l'Outine cases. These arc instances in which the genetic risk is low and where the
clients do not require clinical management (lor example, a client is eager to knoll'. out of
curiosity. if their particular condition ha;: a genetic component'"'). I\s l'Outine cases arc
prevalent, they arc olien lelt to "Ianguish a tCw years" [#71. as disease management is not
With the triage systelll in place, the goal is to give clients - including non-
urgent (routine) cases - a fair chalKe to be seen within a year. [1111
However, thepal1ieipants indiGlied that the wait time tiJran appointillent with a
medical geneticist could sOllldillles be up to tive years; li)r a genetic counsclor
specializing in cancers, it could be three years; and till' a general genetics consult. one
year to 18 months.
In terms of wait times tor obtaining the results of genetic testing. these depend on
the type of test needed.
That can range ... two weeks would be the shortest turnaround tillle to get
a blood test back, up to Illay be four IllLJnths Ii))" a clinical DNA test ...
can't think of any that is longer than that amount oftillle. [#2]
Participants indicated that they also order genetic testing ttlr the purposes of
research. As explained earlier, genetic research is an integral part of the gendie services
systelll, and research-based testing is an option when no clinical testing is available.
Obtaining research testing results may take years.
We send otT a 01 A sample to some research lab that we an; not paying
for [occasionally. research labs may not require a fcc ttlr tests pertill'J1led
as part of a research project] and that can take a month-to-ncver to come
hack. So it eould be inddinite in terms of how long it would take to get
results back from our res,:arch laboratory because they have no ohligation
to tinish that study or whatevcr thcy are doing. or thcir study is so long
that, you know. thcy may ncvcr gct to our samplc wc scnt thcm until cight
ycars later or something. [#1]
So if thc DNA samplc ',vas collccted maybc 10 ycars ago. it was unly
rcccntly. rclatively recellily. tcstcd bccause thc gcnetic tcst has only bccn
rcccntly availablc. [#41
I\nothcrparticipantcommcntcd un the unccrtaintyassociated with wait timcs Illi'
tcst results whcnclinical paticntsaretcstcd through rcsearch.
For our hcrcditary calun canccr lamilics, a lot of tcsting is bcing donc
through rcscarch. And with rcsearch. you ncvcrha\'casct timelinc. [#31
Whilcthcrcisatriagcsystcmto,:stablishcascpriority, thcset timelincs arc not
always mct. In hlCt, thosc triagc-based tilllelincs are somcwhat arbitrary - thcy arc not
bascd on any standard guidelincs. According to onc rcscarch participant, thc triagc
process rcccntly implcmcnted at the PMGP at thc timc ofthc intcrvicws was concci\'l:d
locally and may not bc in kccping with thc proccss at othcr gcnctic ccntrcs across thc
country. Onc participant commcntcd thai thcrc is not really an in!i'astructurc in placc to
cvaluatc ifin blet thc PMGP is mccting thc objcctivcs thcy sct thcmselvcs in tcrms or
Il)lIowing timc!i"amcs. Whcn back-ups occur due to a high volumc 01" clicnt liles, thcn
locumsarcbrought in to assist with the \vorkload and to rcduccthc wait timcs.
Evidently. the wait time Il)r a client to bc seen by a medical geneticist can he
1~lirly long: it may take a year, two years, or even live years. Likewise, genetic testing
may at timestakeyearstoproduceresulls irany'.J. One informant summed upthe
relationship of this particular harrier (wait times) to systemic barriers in general:
If you arc going to reduce the wait times. then there has to he more
funding tl)r more personnel to do the work. [#]1
3.5 Barrier # 5: Genetic Literacy of Physicians who arc not Geneticists
The participants made a strong argument that, in addition to the nced Il)r
adequately resoureed genetic centres, an important determinant orthe quality of genetic
services is the knowledge that medical professionals (non-geneticists) have ahout
gcneticsand clinical genetics in particular. The participants reported that there are
inconsistencies in terms of the dcgrce of genetic knowledge held hy 1~I111ily physici;l1ls
and medical specialists (non-geneticists) Onc genetic practitionerelaboratcd:
There are some peoplc that arc what I would call ourregularrcrcrrals.who
undcrstand what we do over here and send a lot of paticnts our way. and
those peoplc know very wcllwhat's going on. Thcre are othcr physicians,
I think. who have less of an idea of what we're doing and somctimes will
only refer maybe because the paticnt has asked Il)r that referral. and then
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there's ...c1early there's physicians who do not know anything about \\'hat
we do here and do not refer. [#21
So I guess awareness among pbysieians in the specialty group is really
what generates referrals of clients into our services... [#-+1
It was suggested that targcted infllllllation directed to t~unily physicians would
make that particular group ofnon-genetijsts more aware of what the PMGP is doing:
Ideally, it would be nice iI'every family doctor's office had, you know, a
poster that addressed the question: do you have this and this in your I~unily
and here arc the people that can help you with that.l#3]
Participants also alluded to the g~ltc-keeping role that t~ullily physicians play in
the process of genetic care delivery.
The hUllily physician hao; the power to move them [patients 1 along the
system. [#6]
We rely now on hUllily duetors to assimilate the l~lCt that there is screening
program available. We I'ind Ihat there's not enough uptake of patients that
come in through that mechanism. [If-+I
Rctlcctingon thc importanceoflhe knowledge level of other health providers.
and medical specialists in particular,oncparticipant commen ted:
It depends on the information the specialist has. So. really it's how
inllJrmed is your specialist who's treating you - your attending
physician - whether or not they promote genetics as being part of a service
that's available to you. So that's haphazard. [1141
However, as mentioned previously, the program's capacity to handle more clicnts
is a huge hurdle to the desire to increasc effective referrals. When t~lInily physicians or
other non-genetics specialists choose no! to move patients through the system, the
bottleneck point (that is. the wait list of clients to receivegem;tic services) is cased
considerably; yet keeping patients from being referred to genetic care is counterintuitive
to the goal of the PMGP. f-lence. recognizing the strategic importance of the rekrring
physicians and reducing or eliminating any obstacle they I~lce in their role of referring
patients to genetic care is essentialllJl' the steady operations of the Program and its
elleetiveness.
II' we have every single dodor in the province understanding genetics, it
would be live years bctl,re you can have any appointments becausc the
referrals would be too many. Ilowever, they have where to send people
and some knowledge is going to move along. [1151
Genetics awareness and adequate knowledge arc central in achieving the balance
between appropriate referrals and under-orover-useofreferrals to genetic care. It seems.
thl:n, that ddil:il:ncil:s in gl:ndic COl1lpl:tl:ncies Sl:el1l to have a dual rok: thl:Y prl:sl:nt a
chalkngl: to the gendic sl:rvices by limiting or divl:rting aeCl:SS tll gendic carl: tix tllllSl:
who would bl:netit li'om it, whik at the ~;ametiml:, the lack ofappropriatl: rdermls
provicks a bl:ndit to thl: eUITl:nt system, given that thl: current syskm can handll: only a
limitl:d number of referrals. As a prerequisitl: tor dlieil:nt gl:nl:tic sl:rvicl:s Startidd l:t a\.,
(2002) recomml:nd that family physicians be knowkdgeabk and conli,knt to ,kal with
gl:ndic problems. However, gl:nl:ties l:dllcation tllr physicians (non gl:ndicists) is only
Illinimal and nl:l:ds continuous update given the rapid advanel:s in gendics (Callllidd,
1999; Metcalfe, Hurworth, Nl:wstl:ad, & Robins, 2002; Klitzl1lan, 20m). Contrary to
what the majority of the participants statl:d and what the litl:raturl: arlirms, SOIlll:
participants cOIllI1ll:nted that physicians Inon-gl:nl:ticists) havl:"much 1ll0lT pl:rspective
about gl:nl:tics than they arc given crl:dit tor" [#5]. According to one participant [1151, thc
majority of physicians arc willing to rdc-r patients to the gl:nl:tic clinic, ho\\,evl:!", thl:Y do
not choose to bl:CC1USl: of concerns regarding continuum of gendic carl:. Anothl:r
participant comml:nted:
1 feel likl: thl: l1lajority of physicians in I l:wtilundland and Labrador arc
rl:ally aware of the genetics in the province and arc ,'cry good at Illaking
rdeITals. I'Vl: worked othl:r placl:s where doctors out thl:re don't l:ven
know that the gl:nl:tic department exists and thl: relCrrals arl:n't
appropriate. But I'd say the majority of physiciansjust make their rdl:ITal.
Ilowever. I do not get th~ teding that patil:nts arc being educated on the
reason why they're being referred. [#2]
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This observation is not surprising, as physicians have notoriously busy practices
where physician-patient relation time is limited. Moreover. awareness of genetic sen'ices
docs not always translate into adequate genetic competencies~mcdical proli:ssionals
(non-geneticists) may not be fully conlident in discussing genetics with patients and may
choose to deter such conversations to th,~ genetic specialist to whom the patient is being
reterred. These lindings parallel what has been described in the literature. Results from a
U.S. survey revealed that more than 90 per cent of medical professionals had no training
on common genetic disorders (Maradiegue, Edwards, Seibert, Macri, & Sitzer, 20(5).
Rcsearch on a U.S. population has also shown that paticnts have concerns and arc
dissatislied whcndoctors bil to direct thcm to propcr genetic int(lrmation ortreatmcnt
options, suggesting that there is a need li,r furthcr cdueation (Bccne-Harris et al.. 20(7).
Metcalle ct '11. (2002) conducted researe'l on Australian medical proli:ssionals' vicws on
thcir own level of knowlcdge of genctic>. The physicians selt~assessed thcir
competencies as inadequate. indicating t lat they underutilize genctie scrvices and claim
low relevance of genetics to their practice. Similar arc the findings of Suther & Goodson
(2003). who rcvicwcd publishcd litcrature on primary carc physicians' pcrspectivcs on
thc barricrs they experience in providing genetic care. They discuss inadcquate genctic
knowledge of primary care physicians a~ a barrier to gcnetic scrviccs and dcscribe thc
low conlidence Icvel of physicians in as,essingand rcferring patients to gcnctic care.
Unmistakably. the majority of participants I intcrviewcd kit that thcre is a gap in
physicians' gcnetic knowledge and that this lack of knowledge is a barrier to acccss to
and up-take of gcnetic care. Their views arc well supported in thc litcrature. suggesting
that then.: is a need in Newt'illlndiand and Labrador liJr doctors to obtain continuing
education in clinical genetics.
3.6 Barrier # 6: Post Referral Attl"itioll
One research participant elaborately described a number of scenarios arising with
already referred patients.
3.6.1 Communication with attelllding physician. According to that genetic
prokssional,somepatients ICel uncomk,rtablesaying"no" 10 their physician when
rekrred to the genetic clinic, even when they arc hesitant about availingofgenctic
services. These patients subsequently do not present to the clinic, ordiscontinllecare.
situations that produce the same result a"a non-referral.
3.6.2 The hurden of completinl! lengthy information forms. Several
interviewees suggested that the tlllllily history questionnaire which e1ients arc required to
complete is a huge disincentive to pursuing genetic assessment. The liJrlll is a Illirly
extensive document and some patients lind the questionnaires overwhelmingly complex.
Nevertheless, it is essential to have the Illlllily history completed. as genetic professionals
usc it to conligure a pcdigree necessary to determine genetic risk.
We send out Illmily history questionnaires to get the pedigrees. We lose a
certain portion of rcrerrals that way. People arc just not willing to lill in
these forms. [#3]
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The turn-around time tiJra patientJdient to send the required intiJrll1ationbackto
the genetic professionals deterillines to a great extent when that paticnt can be dinically
ascertained. ThePMGP hasathreeillonth turnaround deadline liJrreceivingboth the
l;l111ily history and the release ofinltJrll1Uion ttJrll1 (which consents to contact with other
l;l111ily members). To ensure the timdiness of responses, the genetic dinic follows up
with patients via telephone every 30 day-;. up to three times. as a reminder to send back
the completed documents. Patients an; offered help with completing the liJrlllS ifit
hecomescleartheynced it (that is, if they request help or return theliJrll1swith
incompleteinttJrlllation).
Part of the problem is that people are overwhelmed by all the paperwork
that needs to be done. Maybe we could devote more resources to getting
the information over the phone rather than doing it by a ItJrlll. [#51
The more recently established colorectal cancer screening clinics usc an improved
vcrsionofthe PMGPquestionnaire, whcrecertainquestionsareconsolidatedandbetter
articulated to alleviate e1ients' confusion and save time. It is premature to compare
attrition levels in terms of the two \'ersions of the questionnaire.
3.6.3 Communication hetween family memhers. Once a patient pedigree is
conligured. genetic professionals need te, obtain additional intiJrmation regarding discascs
that haveoceurrcd in the l;lmily. flaving l;l111ily mcmbers sign a releasc liJrlll enahles the
collection of this information. This requires communication with Inmily members. a task
that patients may lind burdensoille. Gendicprokssionafs reported that sOllle patients are
not willing to communicate with rt:lativcs to ask thcmto sign the rt:lcase ofinliJrlllation
tiJrIll.causingat least a 15%clicntdropoutratc", Asoncparticipant put it,
II' thcy [patients] go through scnding in thcir papcrwork and thcy talk to all
their tlul1i1ymembers. by that time they arecommitled. Otherwise, we lose
a certain sub-set ofpeopk. [11:1]
Participants explained that the PMGP stallis well aware of the attrition problem.
The Program keeps track of "lost clients" and has been working to I'ind ways to overcome
this hurdle,
More research is clearly needed on post rclcrral attrition as a barrier touptakeof
genetic care, I-laving patients rclclTed to tbe genetic clinic ti)r assessment and losing those
patients partway through the process is costly li)r the system and possibly li)r the patient
il'extensive travel or other arrangements were incurred. More importantly. there is a lost
opportunity to provide and receive genetic care that may be time sensitive tilr the patients
and their Iltmilies, and desired health outcomes may not be achieved,
Chapter 4: PS~'chosocial Barriers
In this Chapter, I t()cuson how gcnetic profcssionals have undcrstoud and
interpreted thc psycho-social challenges expcrienced by individuals and t(unily mcmbcrs.
The privileged position of genetic profe>.sionals as providers ofserviccs is kcy to a full
asscssment ufthe challenges to accessin~ and using genctic services. Genetic
prorcssionals have direct contact with patients and 1'(1Il1ilies and thus have an in-depth
understanding of the broad range ofcxpcriences of individual patients and t(unilies with
various symptoms and clinical needs.
Genctic professionals' interactions with patients and t(1Il1ilies are influenced by
individual patient characteristics as well as their 1~lmilial and other circumstances.
Understanding paticnts' beliefs about inheritance as well as their sense of vulnerability
associated with perceptions of risk is a fundamental part of genetic professionals' work.
and indeed is imperative for effective gCletic counseling (Walter, Emery. Braithwaite, &
Marteau, 2(04). Geneticists must be con>tantly cognizant of and receptive to what their
clients are saying and not saying (believing, assuming, \'aluing) because doing so is an
essential strategy t(Jr identifying any stumbling blocks that clients arc likely to experience
in the proccss of receiving gcnctie care. In LIe!. genetic protessionals are in the best
position to prevent, mitigate or help overcome some of the challenges to access by tirst
reeognizing them and then exereisingdirect inlluence to overcome the challenges.
Psychosocial issues associated w,th genctic testing have been well examined and
described in the literature (e.g.. Meiser. :;'005; Braithwaite. Emery. Walter. Pre\'()st, &
Sutton, 2006; McAlistl:r, 2007; \ ;lll Ooslrom l:t al.. 2(07). Thl: majority of rl:sl:arch
!()CUSl:S onthl: pl:rspcctivl:s of individuals who pursuc gl:nl:lic carl: and includl:s a broad
spl:drum ofissul:s, including dinicultil:~. discussing gcnl:tic risk withinthl: I~llllily (l:.g.,
Mal:Kl:nzil:, Patrick-Milkr, & Bradbury. 2009; Fl:athcrstonl:, Atkinson. I3haradwaj. &
Clarkl:, 2(06); willingnl:ss or lack ofwillingnl:ss to undergo gl:nctic tl:sting and karn the
tl:st rl:slilts (e.g.. Lawur d '11.,2(08): so·:ial stigma and discrimination rdatl:d to tl:sting
(Smith. 20(7): and anxiety and dcprl:ssion assol:iated with undergoing genl:til: (L;sting
(Douma, Aaronson, Vasl:n, & Bleike, 2008; Shalowitz, & Milkr, 200S; Dixon-Woods,
Jal:kson, Windridgc, & Kl:nyon, 2006; d·,\ginCllurt-C'anning. 200 I; I.ippman. Il)l) I).
l3l:yond what the patients and t~lInilics say about thl:ir l:xpcril:ncl:s of gl:netic carl:
(amply described in the litl:rature). genetil: proiCssionals' pl:rspedives arc key to
ulltkrstanding psychosocial barril:rs to dlcctive and d"tieient gl:netie carl:. According to
thl: genetic professionals I spoke with, therc arl: a numbl:r of psychosocial l~lCtorS
intlul:ncing patients' ability to access gcnetic sl:rvices. It is worth noting that gl:ndil:
providl:rs' commcnts varil:d intl:rms of·.vhethcr or not pSYl:hosocial barril:rs Wl:rl: raisl:d
spontanl:ously: only two partil:ipants talked spontaneously about thl:dirticultil:s thl:ir
clients t~lce: othl:rs providl:d eomml:nlar:< whl:n speeitically asked.
".1 Barrier # I: Lack of Client Awareness of Genetic Services
Many of the genl:tic proiCssional.; I spokl: with wen: concl:rnl:d that thl: gcnl:ral
publil: dOl:s not know that thl:rc is a genctil: l:linic and what its mandatl: is. In f~lCL gl:ndie
professionals saw lack of awareness as a leading challenge in appropriate access to
genetic care. /\.S one participant succinctly put it,
I think that the biggest barrier is probably just awareness that gcnetic
services exist. [ff3J
Interestingly, the level of awareness of what genetic services arc and can do docs
not increase even atierthe patient is referred to the genetic elinic. The assumption that
patients, in particular those referred by a medical professional (non-geneticist), arc being
advised on what to expeclli'om the genetic clinic and have acquired basic in 1'(lI'll1at ion
about the services they are going to rece,ve. simply docs not hold true.
I would say that most people, when they're rderred, don't really have a
good idea of what we can do or what we're going to do, [#2J
I always joke that they [the publici think we're cloning people down here
(laughs) because they ha\'eno idea what weare. [#3]
If they arc new 1~II11ilies I timl that they have absolutely no idea what we
do here. [#6]
... the bulk of people arc pretty clueless, [#1]
Those commentaries overwhelnTngly illustrate genetic providcrs' concerns about
the lack of understanding about genetic care. The PMGP clinic has engaged in some
publicity eftllrts that predictably havc gencrated additional interest:
We'vc donc a little bit .. weean call it somc publicity: I was on the radio
with one of my patients. So we got a eouplc of phonc calls alier that that I
can think of. [#3]
Ethxts to augment public awareness through newsletters, public seminars and
other public torums wercdiseussed by thcgenetie proiCssionals. Raising patient
awareness about thc genetics clinic and thc services it provides was seen by the
respondents as a desirable movc tllr\vard: howcver.lhe lack of resources to accomillodate
an increased volume of clients (as discussed previously) was dcscribed as one of the main
reasons public education about genetic scrviees continues to be insufficient.
Participants reported that public interest about genetic services is increasing: the
number of referrals is swelling, and the wait list is longer in comparison with waitlists in
the recent past. Importantly. genetic professionals lecl that the heightened deilland Ilu'
genetic services is not paralleled by an increased understanding of what genetic services
are and what they can offer to clients.
There are people out thele that have pretty dramatic l~lInily histories of-
you namc it - whether it's cancer or heart disease or such-and-such
disease. I think letting them know that there is a clinic here - that ourjob
is to sort these things out - is the way to improve the service. lin]
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The pen;eption hcld by the genetic professionals that there is a lack of public
awareness about, what genetic services offer as well as lack of knowledge ofgcneties is
in keeping with other studies that haver,:vealed thelackofpublicawarcnessand the
critical need tor public education (McCllren et aI., 200X: Jonassainl et al..2(10).
4.2 BalTier #2: Client Knowledge of Cenetics
Many of the genetic professionals I spoke with IClt that clients' lack of awareness
about the role of the genetic services wa:i coupled with a lack of knowledge about
genetics and inheritance in general. All genetic profcssionals unconditionally stated that
their clicnts' undcrstanding of genetics i:i minimal. They expressed tj"ustration about thc
I~lct that although their c1icnts receive avast amount of gcnetics-rclated information
through the clinic, verbally and in writing in multiple iterations. the inllmnation remains
incomprehensible tor the majority of clients. They emphasized that genetics is based on
probabilities and genetic risk is an abstr<'.et concept that proves verydifticult tlll'lllany
patients to understand. One participant observed:
There arc several barriers that I have IlHlIld. and the tirst barrier is the
level of knowledge. Patients really lind it dillicult to conceive of that thcy
pass on something that lbesn't. ... how they pass it on and you know, thaI
it doesn't gu to one sex or the other sex, and they have a lot of old wives'
tales, inherent sorts of thought processing around it anyway. So to try to
explain that to them and to be able to break it down to them so they
understand it, that's the tirst level. That's the theme that I've eonH': across
most. [#7]
It's strange because peol,le will say, especially if they ha\'e t\l'O or three
sisters they'll say - oh. nlY mother really lucked out because there arc no
boys in our hllnily and you can't pass it onto boys, So there is a real
confusion about it. [#6]
Although the participants did not speeilieally discuss whether ccrtain genctie
concepts were better understood than others, the examples they provided alluded to
diniculties understanding inheritance patterns, Their comments substantiate lindings of
previous research that have demonstrated that the general public and patients havc poor
knowledge of genetics (e,g" Christensen, Jayaratne, Robcrts, Kardia, & Petty. 20 I0;
Falcone et al.. 2011; S ational Science Board, 2008; Moister et aI., 2009). Gcnetic
professionals were espccially concerned that people may be holding and "passing on"
misconceptions about genetics and inheritance patterns that deter them !i'om seeking
genetic care, an observation that is also supported in the literature (McClaren ct aI.,
2(08).
4.2, I Education tlll'ou~h the ~cl1ctic clinic. Individual clients and l~lInily
members arc offered detailed genetic int;Jrmation about genetics and genetic services by
the genetic practitioners. Onerespondenl explained that clients seen in the clinic arrive.
with orwithoutadiagnosis. and the genctic clinic supplies most orthe inti.mnation abLlut
their disease and its genetic basis (provided the gene is known). In cases where the
referring physician mentions a genetic e'.lIldition as a possibility. depending on the
education level of the patients and their internet access. some clients might very well gain
some prior knowledge of genetics and g,:netie services. Howe\'er, the majority of clients
approach the genetic clinic with little or no awareness and typically everything is novel 10
them.
Many of my patients wO.Jidn't know they had a genetic disease until they
saw me, in which case' am the one that's supplying at least the initial
int()rmation.[#X]
Once a client leaves the clinic, they arc already furnished with a great deal of
inl(lI'Illation and support materials, including printed materials and referrals to websites.
Subsequent to the visit. a t()lIow up letter is sent out to the client summarizing the
discussion that had occurred during the consult. In bet, the mandate of the genetic
counselors is mainly to provide education and support to clients with genetic cnnditions
and to address their psychosocial issues. One intonllant argued that this is the reason why
genetic counselors should be referred to as genetic educators. In the same \'Cin. another
inl(lI'IllCl11t attested that their clients' uJ1(krstanding is usually minimal in the beginning of
the contact and. depending on other variables'I>, they will have an enhanced level of
understanding at the end. The 'education' component of the gencticservice is vital as
~I> Variables inc1utk. for cxampk. the c1iclll"s k;n.::1 orrorlllal educatioll. as will he disclissed in the next
sectIon
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clicnts may bc ablc to obtain bcttcr undcrstanding about thciractual risks. as opposcd to
thcirpcrccivcd risks, which accordingtoonc informant arc olkntimcs "intlatcd".
First, I will cxplain to them how gcncs work and how an illncss or
syndromc is passcd on to childrcn, and thc dil"fcrcncc bctwccn rcccssivc
disordcrs and gcnctic disordcrs. I say to somcbody - you havc to havc two
gcncs for this. so your mom and your dad had to havc this in ordcr Ill!' you
to havc it, likc that sort of thing. It's vcry difficult to cxplain thai to thcm
[116]
You know, most cascs of Down's syndromc arc not inhcritcd: and thcn
pcoplc havc a family history of Down's syndromc and thcy think thcy arc
vcry much at risk of having a child with Down's syndromc thcmsclvcs.
just an cxamplc. [#8]
I think wc arc giving th~ paticnts a varicty 01' sourccs. It's actually thc
gcnctic counsclor thal'~; working with thcm and would givc thcm
pamphlets on gcnctics, intormation on paticnt support or rccommcnd
wcbsitcsthatmighthclpwitha particulardiscasc. [1111
ErtlJrls to augmcnt public vigilancc through ncwslettcrs, public scminars and
othcr public tlJrums and Iccturcs whcrc ~Ippropriatc wcrc discusscd by thc rcspondcnts.
Thl:sl:practicesarl:l:SIKciallyrdl:vant \I·hl:n thegl:nl:tic professionals arl: involvl:d in
long-tnmgl:nl:ticresl:archprojl:cts.
So Wl:'ve madl: a conscious dltJrt to make sure pl:opk are inttJrllll:d. Wl:'11
have a nl:wsldter going out. I l11l:an it's just a brid note but Wl: will
lksnibe what we'\,l: don,~ in the past, where Wl: hopl: to go in thl: fUlllrl:. If
thl:re's bl:en chalknges to it, we'll put that into it to say "starting has bl:l:n
an issue" or "funds have bl:l:n l:ut" - somdhing likl: that, so they
unlkrstand. Wl: had a full seminar day and invitl:d the publie and all thl:
peopll: who participated to come here to the Health Scil:ncl:s. Wl: had
spl:akers, Wl: provilkd IlInd1. They had the opportunity to gd up closl:
with surgeons. gl:netil:ists. gl:nl:til: wunselors and that sort of thing. So
that's the way to we try to build bridgl:s and maintain patients in studil:s.
[#6]
Thl: gl:ndil: praditionl:rs I intnvil:wl:d l:mphasizl:d thl:ir l:dul:ational rok. They
explailKd that providing information to thl:ir patil:nts is part ofthl: supporti\'l: rok thl:Y
play ,·tlr individuals and familil:s. Thosl: ertorts appear to be l:Vl:n morl: strl:amlined whl:n
rdated to gl:nl:tic research through which dinil:al genetic care is accessed. Through the
intcrviewsit bl:C,II11el:videntthat the current environment is one of balancing public
awareness of genctics with thl: lksirl: to prevl:nt the neation of a "genetic nl:ed" or
unnecessary tCar(as discussed in Chapter 3).
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Paradoxically, it appears that while the clients and the public seem to have
limited genetic knowledge, the participants reported that. presently, the interest in their
services is more pronounced than ever. This trend is consistent with the tindings of Wang
& Watts (2007). who also note that the genetic profession may not have adeljuate
resources tor increasingly dealing with <Idult clientcle.
An important counter-point to studies on the knowledgedelicit of the general
public and genetic clients is research that argues that the emphasis on clients'
interpretationofstatisticsisamootpoinl. While the genetic service providers I
interviewed did not speak to this point, critical scholars of genetics have arguedthat
clients' understanding of genetic risk will necessarily be reinterpreted in the context of
the riskiness of daily life, and that genetic professionals therelixe arc better advised to
attend to the meaning (rather than the statistical interpretation) ofgl:netic risk (e.g..
Peterson, 1(99). "The publiearl: not passive consuml:rs ofhl:alth education messagl:s. but
active participants in tlKir interprdation and social construetion" (Sandl:rs. Campbcll,
Donovan, & Sharp. 2007, p. 519).
4.2.2 Education through family experience. While discussing thl: inadeljuate
levcl of clients' genetic knowledge, the genetic professionals reportl:d that patients who
had l~lIllily membl:rs with prior l:xpl:ril:nce with genetic serviel:s had a much bettel
understanding of genetics and what genetic sl:rviel:s can offer.
It makl:s a dith:rl:nce what l~lInilies know about genetics and whether or
not they havl: heard aboul a genl: or gl:netics bl:I(Jrl:. [#1]
Another participant used the example ofa t~lIl1i1y with many young people dying
li'om colon cancer:
They [hlll1i1y members] recognize that there is something going on in the
1~1I11ily that is not common throughout the whole population" [#51
In that example, if a hlmily member mentions that because of early detection
through colonoscopy they had a polyp rcmoved and thus did not have to undergo
chemotherapy or radiation treatment, thcnother bmilymembers !lJllowsuitand pursue
genetic care. In other words, the presence of a genctic condition in a givcn 1'~lIl1i1y and
cspecially its successful treatment can mobilize better understanding of genetics and
inheritance. As well, the management of a pre-existing condition by some within a 1~lIl1i1y
may motivate members of the affected t:1I11ily to avail of genetic counseling and
screening, including through selt~referral. Genetic professionals reported that, within
l~lIl1i1ies with hereditary colon cancer, the uptake of genetic testing is high because
individuals want to know if they arc in the high-risk category: the test results determine
the level ofrigor of the screening protocol to be followed. For that particular condition.
given that the screening tlJreolorectal c;JI1cer is invasive and unpleasant, patients prefer to
know tlJrsurehow li"Cljuentlytheyneed to subject themsc!vesto the procedure. By
contrast, the uptake of testing tor other conditions may tollmv different patterns. For
example, relatively higher numbers of individuals in !'~lIl1ilies with breast cancer choose
not to have genetic testing even when it is available to them. The complexity of decision-
making around genetic testing tlJr hereditary breast cancer has been documented in the
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literature (e.g., d'!\gincourt-Canning, 2(106). The relatively low uptake rate can only in
part be explained by the t~let that the benefit of screening till' hereditary breast cancer is a
little less e1ear than tix eoloreetal cancer and some other conditions.
The genetic professionals with \\'hom I spoke also pointed out that gaining
knowledge through the t~lmil/7may lead to misunderstandings and misconceptions, but
lilr the most part, prior familial exposure to genetic care was deemed likely to have a
positive dICet on clients' knowledge and understanding of genetics and the genetic
condition. This is in contrast to the lindings ofSermijn et al. (2004), who illustrate that
even in cases where individuals convey genetic information to relatives. this
cOlllmunieation is unlikely to augment Lunily members knowledge and awareness of the
genetic trait.
-t.2.3 Education through I11cdill. A number of pcu1ieipants mentioned the role of
the media in educating the public about genetics. primarily in terms of the media's role in
misleading the public:
... youlisten to TV, or read magazines or newspapers about a new gene tilr
something, and sometimes this information is given in rather glowing
terms. [1t'5]
.... when genetics gets talked about in the media it's sort of as if it's here
and it's Ii)!" everybody ~lIld it's easy and so on, and sometimes there is
misunderstanding.... [#41
Participants explained that many clients hnve grent diftieulty in grasping the
concept that a genetic test is a test tor n particular fnmily and has to be "worked out" in
an affected h1ll1ily member I-irs\. With a known diagnosis, the genetic test is lirst
pertormed in the proband 5x - ira mutati'.)Jl is detected, the proband receives accurate
intonnation about their disease risks as well as genetic risk int(lrmation about t~lIl1i1y.
This menns that irthere is a test identilicd tor one t~lInily with hereditary cancer, tllr
example, the same test is not available to another hlmily that may appear to have the
same condition, but tor which the genetic basis remains unknown.
Those people kind of have the impression Ii·om the media that. you know,
there is a genetic test tor everything, or they hear about one fllnily having
a genetic test -like the stomach cancer t~lInily - and they don't understand
why their t~lmily can't just have the test; and you have to explain to them
thnt there's mutations ami different genes, and so on .. regardless. they
just wnnt a test so badly. [#3]
thcgCllclicscrvicc
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The media is not talkinl:: about all those other diftieult families that you
can't tigure out the basis. [#5]
The concern is that the media is ~ivingan inaccurate impression that there is
genetic test for every condition that appears to be hereditary. At the same time. the
commentary provided by the genetic professionals suggests that the media has an
important role to play in theeftort to increase public knowlcdgeabout genetics.
Two interviewees spoke about tlie role of the internet as a source ofinlllrInation
about genetics.
My personal belief is that alter we give them our own inllJrll1ation, pretty
much anyone who has al'eess to the internet will look to sec what theyean
tind.[#8]
While not expressed as a signiticant concern by the genetic professionals I
interviewed. there has been a great deal of attention paid in the literature to the potential
harms of accessing genetic intormation as well as genetic testing through the internet.
including the lack of oversight of test validity and utility (Caullield. Ries, Ray. Shuman.
& Wilson, 2(10). the lack of licensed physician involvement. as well as the lack of
consumer understanding of test results ~nd interpretation (Robertson, 2(09). Annes.
Giovanni, & Murray (20 I0) address the mounting unplanned costs to the system and.
most importantly. thequestionablc healih value of tests accessed via the internet. Direct-
to-consumer genetic testing is especially debatable as genetic counseling is typically
abscnt in this type of service. 1\ repol1 i:;sued by the US Government Accountability
Otlice (2010) argued that companil:s off~ring dirl:ct-to-consuml:r gl:netil: tl:sting engage
inmiskading markding practicl:s in an cnvironmentlacking consistency of results. Thesl:
tests can be l:spl:l:ially ddrimentalto pre-symptomatil: individuals who nl:l:d to bl:
thoroughly post-test counsl:led and clinically managed.
In genl:ral, the genl:tic protcssiorals I intervinvl:d werl: concerned that public
knowledge of genetics is inadequate and, even with information intl:rvention through the
genetic clinic (and possibly other source;), the kvcl of understanding ofgl:netics is
insuflicil:nt for inl"(JrI11ed decision making about genetic testing. This continns what
Sturgis, Brunton-Smith, & FiI'c-Schaw, (2010) tound about thl: effect of supplying the
public with int()rmation about genl:ties and inheritance. Those authors demonstrate that
providing such int()I"Jnation docs not generally translate into improved public knowkdgl:
and interest in the science of genetics. !\lore importantly, it docs not signi ticantly alter
fundamental values and beliefs. Patients' knowkdge (or lack ofknowlcdge) was !(llllld to
be on par with the knowkdge of the public at large (sec also Calsbeek et al . 20(7).
-t.3 Barrier # J: Client Attitudes
Fromthl: interviews. it bel:ameclcarthat genl:tic protcssionals invest a lot of time
and etl()rt in providing as much individualized intormation as needed to each client.
Although some clients may contact the genetic clinic with further questions and rcquests
I()radditional int(JrI11ation. thc majoritYilfpotential clients do not. Unsurprisingly, only
somc arc intcrcstcd in pursuing gcnetic care. Gendic professionals' perspectives on who
seeks gcnetic care suggest that there arc two main groups of clil:nts: thosl: who arl: very
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much pro-genetics and those who are ve:·y hesitant. A subset of the first group ofclicnts
bclieves that genetic tests arc able to provide detinite answers. This subset of clients has
dillieulty coming to terms with the limiUtions ofgcnetic testing. In contrast, those who
are more hesitant to begin with are quicker to not follow up with potential genetic
scrvices, either because they remain une'.JIlvineed of the benetits of genetic testing or
because they arc rcluctant to commit to engaging with family mcmbers as part of the
process. These clients arc also most likely to hlil to show up ttlr subsequent
appointments.
The observations of the medical geneticists I spoke with arc congruent with the
work of Cooke & French (2008) who conclude that there is a direct connection between
patient attitudes and their intentions to avail of genetic screening. Thesc authors also
underscore the importance of creating positive attitudes among patients, which translates
into positive intentions that, in turn, enhance the odds ttlr client uptake of genetic
services.
An important observation made by the genetic professionals I interviewcd is that
the decision of potential clients about whether to pursue genetic testing is neither
straighttorward nor prcdictable - bctors such as the level of understanding about
genetics, perceived severity of the illnes:;, and t~lI11ily dynamics are not in themsclves
predictors of clients' attitudes and behavior. Rather, some potential clients aresilllply not
attracted to the idea ofgcnetics and genetic care.
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Some don't like the idea of geneties. Those patients just don't show up Il)r
their appointments. right') [#81
My sense is that people, in general, that don't send in the Il1l'll1S and don't
make the ertl)rt are people that end up not coming Il)r their appointment
olicn. It's a pretty good predietorofwhether they are going to come. [IJI]
.. you look at the referral and you'll think - I need to run alter this a bit
more and you'll try to call them [clients] and you'll get some of the
information over the phone, and you'll hand hold a bit more: and those are
the people that more otten than not .. when you give them an appointment
and then they don't come in. [11:1]
These observations by the genetc professionals are insighth.d in that they relleet.
rather than challenge, the meanings of genetic testing in the context of' everyday Ii fe. As
the limited qualitative research with those who decline genetic testing has begun to
illustrate. decision-making is complex and not necessarily correlated in a straightflmvard
way with a "knowledge dclieit,,5') of genetic inflmllation (Cox & McKellin. 1009: Lock et
al.. 2006; Duncan et aI., 2(08).
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Unmistakably, the above exn:rpls excmplify Ihe added dhJrt genetic
professionals invcst wilh each e1ient to cnsure that e1ients arc genuinely committed to and
interested in genetic testing. Although 11l1llC of the three participants cited above
mentioned the link between patients' knowledge about genetic testing and attitudes to
genetic testing (that is, e1ients' "attraction to" genetics). they seem to operate on the
implicit assumption that full knowledge docs not imply an attitude of attraction to testing.
The genetic professionals reported that regardless of patients' liJrlllal education and
intellectual ability, they only sec individuals who arc interested and have an attitude of
"attradion to" genetic testing; experience has taught them that only the truly committed
tilliow through with the whole process despite its complexities and challenges.
It really varies. Vou ha'ie very, very smart people who arc onboard the
genetics train so to speak - and you have the opposite as well. [#3]
The participants explained that a good predictor lilra e1ient'seommitment is the
compldion of the papcrwork, combined with thorough t~lInily communication. lone of
the respondents was able to provide concrete numbers to better illustrate the e1ient
attrition rate aticra contad with thegel1etie professionals had bcen initiated. Theclinic
docs not kecp statistics on how manyelicnts reccive intiJrmation butdo not lilliow
through with a full range ofgendic testll1g and lililow up scrvices.
4.3.1 Preparedness for and concerns about ~enetic testin~. The genetic
consultation process ddermines whether or no! a client qualities till' genetic testing.
Usually. the presence of a strong I~mily history indicates that a person meets the high risk
criteria that identify them as eligible fur testing. As discussed above, conveying eligibility
infllrlllation to the individual docs not automatically result in a decision to pursue genetic
care. In 1~let, the decision process is complex; it involves indi\'idual and 1~II11ilymembers.
takes time. and can be emotionally charged .
.1.3././ Pre-symptomlltic testil/g. Genetic professionals explained that pre-
symptomatic genetic testing is offered t,) elients who arc clinically healthy but deem cd at
risk for developing a particular genetic disorder. For those unaffeeted by a genetic
condition, this means that a diagnosis is reached bdl)rethepatienthaselinically
experienced disease symptoms.
Pre-symptomatic genetic testing may cause considerable distress, especially ifno
treatment is available (Graceffa et aI., 2009). In those cases, thorough pre- and post-test
genetic counseling and support is imperative regardless of the test results. Fur example.
first degree relatives of patients with genetic disease may not be particularly int<:rested ill
prcdicti\"C testing if therapy is not 'I\ailahlc (Dahodwala et al.. 2007).
There is a vast amount of research documenting the psychosocial distress
associated with genetic testing (Cohen, 1998; Skilton. Prazier. Calvin, & Cohen. 2006:
Duncan ct aI., 200X; Edge. 2008; Fanos et al.. 20 II). For example, Fanos and colleagues
(2011) have described patients' unease when it comes to testing (in the absence of
symptoms) and diselosureoftest result:;. They have demonstrated that at each stage of
the test process, patients have to cope with psychological issues. during decision making
about whether to undergo testing, as well as during the process of deciding whether ur not
to know the test results. The authors also describe the emotional distress at the stage
when results arc disclosed, even if the results arc favorable. Patients may feel anguish
because they have to alter their life long perception of sci f and revise plans to include or
exclude genetic disease (sec also Cox & McKell in, I99(): d' Agincourt-Canning, 2005. Oil
thc complexity of decision making around genetic testing).
Thcgeneticprofessionals I spok!;: with did not raise the issue of distress related to
"favorable" test results, but rather emphasized patients' expcriences with a positi\'c
diagnosis. The participants referrcd to late-onset disorders where genetic diagllllsis,
although beneticialll)r patient treatment, brings a whole gamut ofchanges on the
personalandbmiliallevel.
Some patients arc very anxious because they arc at that stage [of lircl
where there is a complete sense of loss. [rill
Some people that arc retcrred have been living with the disability Il1\'
awhik, whether it's physical or cognitive and. you know. it had taken
them time to adjust to th,; t(let that they arc dincrent. [#Xl
Respondents also raised the issue of patient distress associated with receiving an
indeterminate test result-that is, a result that could not provide clear answers to the
clicnt in tcrms of their status as a carrierofa mutation. It is not unusual that a genetic test
may have been completed on time. with clear-cut results. however it may not beckar
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lI·hat those results mean and evenlllore L1nelear what clinical management can be
recommended based on those results.hlI
I think there was one Jatient who was very angry with me recently.
because she did not understand how her siblings had got the result and she
hadn't. She was angry because she thought her test hadn't been run: in
other words, we didn't do it. Again, it's onen comlllunication that's the
problelll. Her test had b,:cn run but we couldn't put it to one side 01" the
l"eneeortheother.lt'sju,tthatshedidn'thaveananswer.lll7l
The respondents indicated that in some cases, patients' concerns about the distress
associated with learning the results arc "cry strong and. despite discussions with the
genetic practitioners about the benetits of testing, those dients remain averse to the idea
of knowing their genetic risk status.
The interview data suggest that clients' attitudes about genetic care vary. but that
those attitudes determine whether or no·: dients will avail of genetic care or will makean
eft(Jrt to cOllllllunieate with relatives and "spread the word" about possible genetic risk
within the hUlli1y. This tinding supports previous work arguing that personal attitudes
towards DNA testing combined with adequate knowledge arc major determinants 01"
optimal utilization ol"genetic testing (Calsbeek et aI., 2(07).
4A Barrier #4: Family Communication
Communication with thc t:.lI11ily:lnd within the family is critical not only in terms
of producing accurate pedigrees and assessing risk but also in terms of informing and
possibly recruiting at-risk relatives. Genetic professionals reported that, although
important, genetic inlormation (including genetic risk) is not always communicated rrom
clients to family members.
Some people then are not willing to contact their relatives to ask thcm to
sign the rclease I'orm and things. So then we lose a certain subset orpeople
this way. [#1]
There arc families that do not pursue things because the 1~II11ilics just do
not communicate wei L and we all know 1~II11il ies like that (chuck les).
Yeah, they've lost touch with their lamily because. what happens a lot or
times is the person rclcrred may not even be a person who's had cancer
themselves. It is because of their t~1I11ily history of cancer, but they're not
able to go and contact their lamily members bccause either they've lost
touch onen because of cancer or because they've cut oil contact. lin 1
While talking about the importanceofeommunicatingal11ongrelativcs, one
participant noted the distress that genetic protcssionals may experience whcnl~II11i1y
membcrs do not contact the clinic. The reasons can vary, however, not conveying the
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inll>rIllation can be a key barrier to uptake of service by 1~\I11i1y members who arc eligible
!l)l" genetic testing.
In terms of barriers. there is always this population within e"ery bmily
who never come to sec me. and it is not because they live in another
province: they li"e here. That makes me nervous about whether they're
gelling our information or not. If the relatives aren't telling them IlH'
whatever reason, then they arc in the dark about it. [#2J
While discussing possible reasons for this reluctant behaviour, the participants
mentioned that hImilies do not always cl1mmunieate well. Family dynamics vary,
depending on degree of kinship, the c1o~;eness of relationships, and how olten contact
occurs. These observations contiI'm others' tindings (Claes et aI., 20OJ: Gaffet aI., 2005:
Koehly et aI., 2(03), that first-degree relatives arc more likely to be in tl>rIll cd compared
to second and third degree relatives (Voset aI., 2011: Clarkeet al.. 20(5).
Inevitably. staying in touch with t~1Il1ilies is not always achievable. Geneticists
reported that lost tics. due to various hImily dynamics or geographical distance. were
li-cquent scenarios in which a client may not be in a position to. or is not willing to
convey essential genetic inll>rIllation to t~lmily members. Consequently, only a certain
percentage of patients contact their relatives. even if the relatives live in the saille or
nearbycoillmunities. Interrupting the tlowofgenetie risk intl>rIllation provided by the
geneticists compromises the effectiveness of genetic care Illr both the patient and their
relatives and creates a barrier to the uptake of genetic advice and care. The challenges in
communicating genetic inl(JI"1llation to t'.unity members as reported by the participants
came as a surprise in light or the fact th<tt the population of the province is known 10 have
very strong family and community attachments.
I guess one thing I always wonder about is when I sec a I~unity that we've
identified a dominant gClle in. and say there arc 20 siblings in that 1~lInity.
they all live in Newtoundland, and yet, I never sec all 20 of them. They
never come in. I am not sure whether they [patients! have convcyed the
inhmmltion properly to the other siblings or they are mad at their siblings
and they don't talk to them .... And we say. "Tell them [your siblings] by
phone or in person or cc'py the letter that I sent you and just givc it to all
your relatives". But you know, not everyone is doing that and so this is a
barrier. [#2]
The participants alluded to lhedifticulties their patients may have in
communicating complex genetic inhmTation due to a lack of appropriate t(mllal training.
As previous studies have demonstrated, patients' lack ofknowlcdge about the science or
genetics may exacerbate barriers already in place due to 1~lmily dynamics. creating an
unt~I\'ourable context t()r conveying important genetic int(mnation to relatives (Mesters,
!\usems, Eichhorn, & Vasen, 200S).ld Other published studies have brought to light a
wide range of factors influencing patients' ability to cOIllIllunicate genetic inl(JrIllation to
relatives: "In understanding why, and where, int()rmation is likely to be passed on.
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accountneedstobctakcnofeultural.bmilialandindividual!actors"(Forrcstctal..
2003. p. 32-+).
-+.5 Barrier #5: Level of Clients' Formal Education
ProvidcrspL:reeivL:thL:L:duL:ational kvdofpatiL:ntstobL:asL:riousbarriL:r.
cspL:eially as gL:netie information is eomplieatL:d and umkrstanding it can bL: u11lfusing
cvcn !l)rthL: wdl L:dueatL:d. Historically, thL: low ratL:ofadult litL:racy in thc provineL: has
bL:L:I1notable (NL:wllJUndland and Labrador Royal Commission. 20(L\). Onc participant
mL:ntioned thL:y havL: L:ome across a number of diL:nts who arL: L:ithL:r undnL:ducatL:d or
illiterate; this participant was quick to note that thesL:elients are ncvL:rthckss intclligL:nt
and that illiteracy should not be viL:wed as a dderrL:nt to providing full L:duL:ation about
gL:ndlL:SerVlces
Though these diL:nts did not karn to read and II'ritL:. they should not bL:
barred from having the right treatment and the right L:are. [#7]
AnothL:r inl'lmmll1t conlirmccl tillt a diL:nt's undcrstanding of genL:tic inllJrlnation
dcpL:nds to a large tkgrL:e on thL: individual's kvd of !lJrlllal education. Genetic
prokssionals attested that. typically, they rdy on written correspondence with clients.
which may also indude inl'l)rmation pL:ltaining to lamily membcrs. During a consult. the
gcnctie prokssionals provide dients with written pamphkts containing in!l)rmation about
gL:neties and suggest that clients access additional inllJrll1ation sources induding
WL:bsitL:s. ThL: issucoflitL:raeywas illustrated ina numbL:rofscL:narios:
We write to everybody and send a family history to everybody. But if you
can't read your letter and your t~lmily history or be able to tllllow it or
know exactly who a lir,t cousin is .... 1 think that's a major barrier to
genetic services and genetic testing here. [#7]
We contacted this pati~nt three times and they didn't come in. So
thereillre, wc assume then they don't want to, when we don't have a clue
whether they actually can read the Iclterinthe first plaee.[11:\1
It was also noted that ifclients arecontaeted in the context of clinical gcnetic
research. then the clients' education is not such an obvious barrier despite the hlct that
illiteracy is a particularly serious problem in the province. This is because clinical genetic
researchers travel to various communiti:s and establish personal contact with members of
the affected families: direct verbal contact lessens the importance of attention to written
correspondence with those patients. Ont; genetic professional described this as a "\'ery
intensive, verbal connection." [#7]
If they [c1ientsl arc illiterate, which quitea few people arc in this province.
the researchers can do that [provide intllrlnalion] verbally and they can do
that so they know themselves what has been understood [by clients I· [1171
Genelieresearchers, then, have the opportunity to learn through direct Cllntact
with a range of 1~lmily members about the t~lmily history without relying on written
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communication bctwccn t~unily member';, Through thl:se personal encounters within the
I~unily. genetil: professionals acquire a sound understanding of the relationship among
1~lInily members, even without asking specitic qucstions, As well. researchers l:an directly
supply information about genetics and gl:nl:tic risk to c1il:nts and more imml:diately
recognize whether or not the int<JrInation has been understood and to what extent.
In the l:ontext of clinical genetic research, the challenges posl:d by client literacy
and educational level maybe less pronounced, but they still exist. Genetic prolcssioJlals
who arc researchers report needing resources and time to travel in ordn to pay homl:
visits to families and provide each memherwith genetic inl<JrIllCltion spl:citicto their
t~unily, This requires the presence ofsunicient and continuous funding. One gcnctic
proiCssional explained that. t<)r linanl:ial reasons. they increasingly commLlIlicatl: with
clil:nts over the phone although they fully realize the advantagcs of flce-to-t~cecontacts
in providing an optimum environment li)r building rapport and 1~lcilitating interaction,
The literature has paid particulal attention to the positive role of higher education
in understanding genetic int<)rmation (e g" Calsbeek et al.. 2(07). Fewl:r studies ha\'e
addressed the role of adult illiteracy in the context of genetil:s (e.g., [rby. RotcI'. Larson.
&Cho, 2007; Lubitzetal.,20(7)(,2, The ability to rl:ad and write is particularly
important in terms of the eflicicnt colledion of hunily history in creating accurate
pcdigrel:s,
din;,:"l ,,"~;n g~n,:ral (,:,g .. I'irim<:, &Sn;\'dy, ll)l)9)
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....6 Barricl' # 6: Clicnt Fcars
Genetieprotessionals reported that the need to respond to a c1ient'semotional
vulnerability by providing emotional support is as important as the eft(lrt to ensure that
inl(JrI11ation is understood and retained and that the client's interest in pursuing genetic
care is not compromised_
You just take each person as they come and try to sec what thcir rcl:lings
arc and if you can help them. [#3]
Not surprisingly. the participants reported that clients may expl:rience anxiety and
rcar that their genetic test results arc going to be positive. They emphasized that clients
onen have unsettling thoughts about how their lives arc going to be affected and how
they arc going to cope with a positive result. This was seen as partinllarly true I(lr
individuals with adult-onset genetic conditions. some ofwhicll can be lite threatening.
If you lind out about your genetil: l:ondition at 50. there's not much you
can do about it. There is no doubt that's a huge area of concern and a
dinicult issue to come to terms with. [#81
Two of the partil:ipants reported that. typically, rcar was not common among their
clients and dl:scribl:d thl:irclients asgelll:rally birlyoptimistic. TheYl:mphasized that the
majority of clients believe they arc in control of their own hcalth regardkss oftl:st
outcomes and that they arc prcpared to ,.lVail ofsl:reening to "avoid something
l:atastrophic Ii-om happening based on that gene". [#4]
Genetic professionals explained that due to their training, they arc constantly
aware that the information they arc giving to a client may cause emotional distress. When
a patient is tested through the cardiac c1ilie, IlJrexample, and is IlJUnd to carry the
defcctive gene (which immediately puts their children at 50'};, risk), they typically
experience anxiety and fear in relation tc- their children's health. Forrest et al. (200J) refer
to this as "generational responsibility," whereby affected parents arc eager to inllJrlll their
children and even their nieces und nephews to ensure the timely disclosure ofinflJrlllution
to allow udjustments in life-course plans Other studies (Tibben, Timl1lan. Bannick, &
Duivenvoorden, 1(97) have demonstrated that carrierpartners l "] with children were
signilieantly more distressed than those 'vithout oftspring. In keeping with these lindings.
the genctie professionuls I spoke with reported that individuals without children may
choose to not even have genetic testing.
There is a compelling hody of evidence on the el1lotional impact that genctic
testing may have, ineludcd elevated anxiety and elinicul depression associated with
genetic care (e.g., Jones & Clayton, 101:;.; Douma et al..l(08). The interviews in this
research did not discuss this.
-t.6.\ Role of ~cnder. Only one pUl1icipunt identilied gender as a harrier to
uccessing genetic services. The inflJrlllant ohserved thut Newllllilldiund men arc very
reticent uhout coming in for genetic treatment. According to the inflJrlllant, women arc
considerably more receptive to accessing genetic services. Women also provide a great
(,t I his refers to cOllpks in which at Ica:-:l olle of the partTlers i:-: a carrier ofa dd~clin.'gent:
amount of encouragement and support to men. aiding the men to pursue genetic advice
and care.
The women try and make them eomc in and they don't want to eOll1e in.
And that's sort ol'licd a bit with their education as well, you know, il'they
len school again at 12 and didn't really sort 01' gel into the health care
system. [#6]
And he sort of grunted a yes becclUse his wit\.: was sitting next to him, you
know, and ... anyway, so on the day he was supposed to come in IiII' this
treatment the lab downstairs rang and said. "Yourpatient hasn't arrived"
I know this is strange. So I rang his wire, who was at work, and she said.
"The bugger! I-Ie's not tUlnecl up! I'll make sure he turns up. [1161
The participant went on with the story to explain that lhe wil'e then alerted and
mobilized the entire community and they loeilted the husband. which turned out 10 be
important. as the man had an al'ICeted status and bringing him in fiJI' the procedure in hlet
saved his life. This example may present an extreme case li'om a number of perspeclives.
however it serves to illustrate the point that men in general arc deemed to be particularly
disinclined and distressed when urged to seck genetieeare. This respondent's amusing
and livclyobservations arc in agreement with the literature on the subject of gender and
genetic care. A number of studies have shown that the genders engage ditferentially in
genetic testing tllr conditions where hereditability is gender neutral (Taylor, 2005:
Creighton et aI., 2003; Hayden, 20(3).
-t.6.2 Confidentiality. Genetic pmfessionals commented that conlitkntiality is
onen something that their patients worry about. They reported that the concern is with
whether or not one's genetic inflJrlnation is going to remain in the genetic e1inie and. if
not. to whom it might bediselosed. One participant described how genetic professionals
typically respond to a patient's anxiety on the issue ofcontidentiality:
Well. the f~unily doctor doesn't get the genetic result. The genetic results
arc released to that patient and not to the family doetor. So right now, it's
how we deal with that. I don't know if that's a perfect system or not.
That's how we deal with it. [#~]
Another genetic professional explained that they ask their clients if they prefer to
have their genetic intllrmation ineluded in their hospital chart. Ifelients approve, only
then docs the intlJrlnation become part of the record. However. the participant ;ldmitted
that they recommend that the bmily history remain part of the record in case a client is in
a medical emergency and cannot speak tor themselves. Alternatively, releasing genetic
inllJrlnation, including results from genetic testing, to f~1I11ily members is aecnmplished
only through a valid consent.
One participant added that observing conlidentiality is challenging in cases where
they sec multiple members of the same Lunily.
You can imagine how that bccomcs difticult whcn I'vc alrcady sccn 10
pcople li'OI11 his t~lI11ily and I am sccing the Illh one 11l:re and I am trying
to cxplain to them why they'rc hcrc, and I havc to say, like, your aunt and
unelchavethedisease.[/i'2]
I say like, yeah, there's a reason why you're here. I\nd ha\'e to explain it
in general terms and usually they know ... obviously, they know that these
people are aftccted, but every once in awhile they they're like--oll, I didn't
know he had it. You kn<Jw, like there is a bit of inf() that they may not
know, and it's always thiS balance of trying to be ... trying not to give too
much into about their 1~lmily but enough so that they understand the
significance of the disea,e in their htmily and how it's alkcting people. I
mean, tech nica II y, that'~: a breachoI' eonti dentialit y, but yo u have to
decide what and how much. [#31
Evidently, the difticulty is around weighing the commitment to confidentiality
against the benctit of releasing importan: int(JrI11ation to a relative to better illustrate their
need to pursue further genetic assessment and treatment.
In extreme circul1lstance:;, you can breach conlidentiality I()r some very
good reason. Then you have to have a whole ethics meeting about it and
get more than one person to agree with you that you really need to go that
route and breach that conlidentiality. [#1]
This conccrn cxprcssnl by thc genctic providcrs echocs the cthics debatc on thc
issuc ofwhcn and wherc a wntidentialily/privacy brcach is acceptabk (Sudell, 200 I:
Knoppcrs, 2002; Pullman & HodgkinsoJl, 2006). Intl:t'estingly. only onc intimnant
obscrvnl that contidcntiality and privacv arccxpressed in a rather pcculiarway in
NcwliHindland, espccially in rural areas. In the participant's view. cvcryonc in a givcn
cOlllmunity "knows c\'Crything about everyonc" and to substanliatc thc statcllll:l1L
provided an example where an cntire l~lInily history had been prcscnll:d to the gcncticist.
without a requcst, by a person who was not cvcn rclakd to that particular t~lInily.
I do not know, bUI Ihcs(' slorics arc vcry intcrcsting bccausc, you know.
Ihcy would ncvcrhappcn anywhcredsc I'vccvcr workcd. [#7]
It appears thaI. in rural Newfoundland. the scnse of comill unity and bdonging to a
community is gcncrally strongcr than the scnsc of being an autonomous individualwilh
privacy rights. In thosc rcmote arcas where cvcrybody looks alicr cvcrybody,
conlidentialityofgenctic intiJrmation may be a non-issue tilrsomc individuals.
Undoubtcdly. rural Ncwtoundland has its own distinct culture which tiltcrs through thc
way gcnctics is practiccd there. Thc gcnetic protessionals I spoke with cmphasi/.cd that
Ihc lack of conlidcntiality among community Illembcrs and I~llllily Illclllbcrs is not
ddibcrateorwith Ihc intention to harm; it is partofthc mutuallysupportivcculturcofthc
sillalliso!atcdoutportcoillmunitics.
4.6.3 Discrimination. Intill1l1ant:; reportcd that the IllOSt important psychosocial
barricr to the uptake ofgcnctic scrviccs is palicnt awarcncss and knowkdgc, but Ihc
s<.:cond major conc<.:rn is tCar of discrimination. whdh<.:r rdakd to <.:mployability or
insurability. Conc<.:rnsabout insuranc<.:discrimination hav<.:b<.:<.:n wdl d<.:scrib<.:d in th<.:
lit<.:rature (C'am<.:wn. Shnman. iVIarl<.:au. 8.:. 131\)\\'n. 200l); MOlTen. Rijk<.:n. 13~I<lIHkrs. 8:-
nCllsing, ,2(07). Th<.: g<.:netic proiCssionals I spok<.: with provided coner<.:te examples of
how insurance and <.:mploym<.:nt discrinl' nation hav<.: diseourag<.:d th<.:ir patients to I'urth<.:r
pursue gendi<.: services.
[T]h<.: biggest problem with g<.:n<.:tic testing is th<.: bet that ther<.: might be
problem with insurance. A far as I am coneern<.:d, that's the very bigg<.:st
thing. That's what turns p<.:opk oil and that's what worri<.:s p<.:opk. [l/6]
Th<.: bigg<.:st eonc<.:rn that p<.:ople have is wh<.:th<.:r th<.:y won't b<.: able to gd
a mortgag<.: b<.:caus<.: of the insuranee ... wh<.:th<.:r, you know. thn<.:'s job
disnimination or won't he able to gd life insurance. If th<.:y w<.:r<.:n't that
worri<.:d, th<.:n far more people would be abk to mak<.: a (kcision on
wh<.:th<.:r th<.:y want a genetic t<.:sl. B<.:<.:aus<.: th<.:y don't know what might
happen with that insuranl;e kind ofissu<.:. th<.:y may put it ol'l'e\'<.:n though
th<.:y. I()rtheir m<.:dieal, w'luld like to have a g<.:n<.:tic t<.:sl. [#11
If people are going to say no, in my <.:xp<.:ri<.:nce, it's mostly b<.:Glus<.: of this
conc<.:rn about what's going to happ<.:nwith insuranc<.:. [#2J
The other big issue is abl)ut the insurance. What I say to them is thaI their
charts do not merge with their medical chart. But the insurance ClJmpanies
arc now getting smarter and they say. "Have you ever seen a genetic
protessional? Have you c\'er had a genetic testing I()r a genetic disorder')"
So that's the other big issue that ... you think you're one step ahead and
then the insurance will just get one step ahead bster. [1f71
Other examples given by the interviewees demonstrate that some e1ients hear
about denial of insurance b'om others. w;ually relatives. Because of prior. although
indirect. exposure to insurance implicati'.lns,e1ientsareconcerned.
They'll say, you know, "My brother - he can'l get insurance because he
has polycystic kidney disease", you know, or "My brother told me lhat he
couldn't get insurance because he told lhem that he got this test done". So,
yes, because more and ll1'.lre people arc getting into insurances and stull-
then. yeah, it's ... they're heClJming more aware of it. 1#5]
The examples provided by the genetic protessionals have eel1ainly shaped their
own belids that the fear of discrimination is a roadblock t(Jrelients and is a potent
deterrent to the uptake of genetic care. This is in concert with findings in other published
studies on the issue of tear of genetic discrimination among patients (e.g.. Powell,
Chandrasekharan, & Cook-Deegan. 20 I0; Peterson et a!.. 20(2).
Contrary to what the majority of participants reported. some researchers in
Canada argue that insurance discrimination based on genetic status isa non-issue. While
thcy acknowledge that there is a lCar of genetic discrimination, they point out that the kar
is not substantiated and there is no need tor a genetics-based antidiscrimination law in
Canada()~ (Lemmens. Pullman, & Roda!. 20 I0; Lemmens. 2003). Regardless of the
debate on whether or not Canada needs legislative protection against genetic
discrimination, the perspeeti\'esofthe gGnetic proICssionals' interviewed clearly indicate
that clients' tear of insurance or employment related genetic discrimination is a barrier to
the usc of genetic testing.
4,6A Social stigma. One genetic proiCssional raised the issue of social stigma
related to genetic status. The respondent shared a storyofa woman who had rcportcd that
the community had singled out her I~lmily because of their particular genetic condition.
he said. "All my children arc grown and they're moving away and' don't
want them involved with this, becausc", she said, "it uscd to be a joke in
the community --they would say, 'don't get involved in so and so hecause
they're going to die on y'.lU anyway'''. So that was really difficult. Sn she
said, like,'" don't want til be in\'olved in this [genetic testingJ. I know the
P. Illcolilltcrpl,illi III Ihal. arglllllCIlI. hCilillh n.'pon",rTh,ercs<,lloy'k (~lay IX. ~()Il) has described Ihe case llr
hilI' \\'\\·\\'.hcallhzolle.ca heallh le\\'skalliresanidel)l)~l)lJ''i--Yl)lIlg''\\'l'"1al-I'lCes-ilsllraIlCe··hllllIJS-dllC­
lo-!:lthcr-with-hulltingtoll-:-:
int\lrmation might be good, but like we','e had enough with this already"
[#71
When asked how li'equentlythe I:lients express tCarofstigmatization, the
respondent commented that this scenario is an isolated occurrence. I\lthough othcr
participants did not discuss stigma as a barrier to availing of genetic testing. it is worth
mentioning that stigma related to genetic conditions has been described in the literature
(Williams et aI., 2010; Smith, 2(07). Sirith (2007), citing Meiser, Mitchell, McGirr, Van
Ikrten, & Schofield (2005), suggests that the heightened awareness about the genetic
basis of diseases and particularly genetic testing may lead to labeling, stigma and further
discrimination.
Chaptcr 5: Synthcsis of Findin~s and Rccommcndations
This chapter provides a precis of key lindings that emerged li'om the
commentaries of the genctic proiCssionuls whom I interviewed. The synthesis is !()llmved
by recommendations 1(11' enhancing clinical genetics practices within the province of
ewt(lLlIldland and Labrador. The I ewt()lIndland and Labrador case study is then used
as an heuristic device It1l' informing genetic services more generally. Attention is gi\'en to
pertinent policy considerations. Limitations of the study are also discussed together with
recommendations lor further research.
5.1 Synthcsis
The unique geography, history and culture of the province of I ewl(lLlIldland and
Labrador li'ame whether and how geneti: services are accessed and used. The genetic
professionals who participated in this study discussed both the successes of the PMGP
and the barriers to accessing and using the clinical services offered through that program.
Participants also underscored the link between clinical genetics and genetic research.
Participants expressed hope that the lindings of this study will give voice to their
concerns and also help bring about ehan;ses for improved professinnal praetiee and
efficient service delivery to patients.
Issues raised by the genetic professionals illuminated the compll:x and Illulti-
directional relations and transactions invnlved in the provision of genetic service:
between them and their clients, between them and clients' family membcrs. betwcen
thcm and the system, betwecn clicnts and thcir 1~\Il1i1ymembcrs, betwecn clients and the
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system. and so on. Because of this intricacy. the underlying themes derived li'OI11 the data
arc diverse yet never distinct. Thc themes that emerged about access-uptake roadblocks
to gcnetic services were grouped into two broad categories - systemic and psychosocial
barriers - each comprised or subcategorics. Thc scparation betwccn the two types or
barriers and between subcatcgories was intentionally and ar1ilicially constructcd as a
means of organizing the findings and ck.ri fying ambiguity in the analysis and translation
of what the medical professionals conveyed.
5.1.\ Systcmic balTicrs. Systemic barriers refer to practices or situations in the
current genetic services which were rep(lrted by the genetic professionals to limit or
exclude certain patient groups fi'om access-uptake of those services.
Geography was identified by the genetic professionals as a powerful barrier to
accessing and using genetic services. Allhough discussed as a separate barrier. geography
permeates a whole range of challenges identilied by the research participants. The
findings of this study conlirm previous research suggesting that remoteness from major
urban centers poses signilicant barriers t'J accessing efticient genetic care and achieving
better health outcomes.
Access to genetic services is not equal lor everybody. The genetic protl:ssionals I
spoke with reported that a signil'icant proportion of the population in the province docs
not have a family physician and that the turnover rate of medical professionals in the
rurallremote areas of the province is high compared to the rest of the province. They
commented that the lack of 1~1I11i1y physicians is a major barrier to accessing their
spl:l:ialty care. which is largely dependent on the referral mechanism. They also
expressed concern about the levels of genetic competence, as well as allitudl:s tuwards
population genetics, among non-genetic medical prorcssiunals.
Participants explained that acces; to genetic care and related medical tests is
al:l:e1erated ifpatientsare enrolkd in a r,:searell study.
There is a consensus that the delivery of genetic services requires l:onsiderable
expense, ineluding individual costs, costs to the provinl:e, sOl:ietal costs. and costs to
research and development. Although thl: genetil: professionals did not explicitly
categori/.e costs into types. particular emphasis was given to the high cost of running a
genetic clinic and pertorming genetic te"ts with limited material and human resources.
The participants discussed the high cost to individuals pal1icularly where curativl: or
preventive intervention is not available.
Limited personnel at the genetic dinics and heavy workload of genetic
professionals were discussed by the part'cipants as principle reasons Il)r long wait times.
I\ccording to the respondents, the number ofgenelicists in the province is I~r li'om
adequate and it is exigent to secure continuum of care for patients by gl:netic
professionals and/or other specialists.
Not all participants agreed that tl-ereare inconsistencies in the genetic knowlcdge
held by 1~Il11ily physicians and medical specialists (non-geneticists). Although there was a
di\'ergcnce of views, the participants wh,) reported inconsistencies reiterated that those
inadequacies arc a balTier to access-uptake of genetic care. Some of those views arc \\'ell
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supporll:d in the literature, suggesting that t~lInily physicians and medical specialists
should seck continuing education in clinical genetics. However. lack of knowledge about
patients and hllnilies within a community was emphasized as a barrier.
Genetic protessionals also disew,sed ch311cnges to their services associated with
alreadyre!Crred patients (jJosl-rej(-rralallriliulI). The participants explained se"eral
mechanisms through which the genetic clinic loses reterred patients, however they
emphasized two main ways: patient relu~tance to decline a reterral li'om their t~lInily
physician or medical specialist (even when they have no intention of t()llowing through
with the appointment); and the complexities of completing t'~lInily history questionnaires
in relation to managing difficult 1~lmily dynamics.
5.1.2 Psychosocial barriers. This category was constructed to synthesize genetic
protessionals' understandings of client psychological and social barriers to accessing
genetic care. Lack of3wareness about genetic services was identitied by the participants
as an important reason why patients maj not avail of genetic care - some pro!Cssionals
described it as being the most important barrier to the ellective uptake of genetic
services. Interviewees indicated that the PMGPapproaehestheissueofpublicawareness
of genetics with caution - the rationale i~; to curb increascd demand h)r the services and
avoid generating unnecessary !Car of genetic disease among members of the public. In the
same vein, all geneticprotCssionals I interviewed unreservedly acknowledged that their
clients' understanding of genetics is minimal. The respondents were concerned that the
concept of genetics remains abstract and difficult to understand for clients. e"en aller
inllJrlll<ltion intervention. They also emphasized the challenge of education about genetics
gi"en someofthe deeply rooted misconceptions about disease and inheritance that tend
to be transmitted within l~lI11i1ies or communities.
Patient attitudes toward genetics and genetic care were also identilied as a barrier
Thegeneticprolcssionals I spoke with underscored the importance of these attitudes and
highlighted that patient mistrust of the benclits ofgenelic testing is evident even among
those who makea consciousenl)rt to learn more about genetics. The observation that
patient attitudes ancctdecisions about whether to pursue genetic care in a manner that is
neither straightf"orward nor predictable concurs with prior research.
Lack of communication within the t~lI11ily also poses a barrier to access to and
uptake of genetic care. Genetic inllJrlllation obtained through the genetic clinic is not
always consistently communicated between and among siblings and other l~lI11i1y
members. The genetic protCssionals I interviewed expressed worry that patient relatives
may not be adequately intlJrllled about their genetic risk. Lack of communication within
l~lI11i1ies may be due to l~lI11ily dynamics. disease or death of a rclative, lack of personal
motivation on the part of the client. and myriad other reasons. Ilmvever. an inconsistent
I1mv ofintlJrlllation among relatives may also he explained by dclicieneies in patients'
genetic knowledge and skill level to convey complex genctie intlJrlllation or lCar that
(not) conveying genetic risk status within t~lI11ilies may further complicate diflieult l~lI11ily
relations.
Genetic providers indicated that the Il)rmal educationallc\'el of patients isa
serious barrier to the pursuit of genetic care. The participants noted that given the low
rate of adult literacy in the province. they do not exelude illiteracy as a hlctor when
clients ftliJ to respond to written communication. Communicating with those clients in
person orvia telephone may, to a certain extent, ensure that the inlllrlnation is received
and possibly understood: however, this technique is time- and resource-intensive.
Genetic professionals discussed patient lCars as a stumbling block to accessing and using
genetic services. Some pointed out that the fear of discrimination , particularly insurance-
related discrimination, is the second largest barrier (geography being the largest) to
genetic testing. Participants spontaneously spoke about their patients' concerns reg~Jr(ling
conlidentiality -- specifically. having their genetic inlllrlnation disclosed (inadvertently or
intentionally) Il)r purposes unn:lated to health.
Gender was also itkntilied as a barrier to actively seeking and persisting with
genetic care. I\nd, linally, one genetic professional mentioned the fear of potential social
stigmatization and explailll:d that. becau:;e of this fear. availing of genetic testing to
confirm disease is perceived by some patients to be an upsetting experience and is likcly
to be avoided.
5.2 Rccommcndations: Local Contcxt
The results of this rcsearch point to spccilic policy and process changes that could
enhance access to and uptake ofgcnctic :icrvices in the province. I\s emphasized
throughout this thesis, the uniquc social, cconomie, political. and cultural contexts of the
province shape how genetic scrvices arc currently used: these contexts also necessarily
shape whether and how genetic services can be mademDre elkctive.
!?CCOIIIIIICl/dliliOIl #/: Careful consideration should be given to human rcsource
projection and planning to ensure an adcquate number of genetic professionals is
employed within the IJrO\'ince to help ca,c the current workload of geneticists. Sutlicicnt
professional human resources arc also likely to reduce wait times, bettcrrespond to
undcrserved areas, and makework procl'sses more efticient both within the clinic and in
outreach with clients and t~lI11ilies.
!?CC01I11I/Clldaliol/ #l: The CUtTenl PMGP should rethink ways of expanding its
scrvices to additional geographic areas. such as the Labrador portion of the provincc. By
utilizing novcl or existing structures and resources. a number of possible options can be
considcred such as additional travel clinics, new permanent clinics, or services through
community bascd centers. Service delivery through less traditional means, e.g., tele- and
vidco-confcrencing can be utilized more tj'equenlly and in a way that t~tcilitates paticnt
access. Whatever form is selected, eloseproximity to home will ensure uncomplicated
access to genetic serviccs and will make it easier tiJr patients to seck genetic care.
!?CCOIII1I1CI/c!aliol/ #3: A provincial education strategy in genetics is needed to
target both mcdical students and practici 19 physicians. It should ineludc programs and
proccsses lix improvcd and continuous I,:,cnetic cducation. including updated guidelines
I(lt' referral to genetic services, and elinical skills training on how to effectively discuss
gcnetics with paticnts. This strategy will help enhance the delivery of gcnetic serviccs.
and genetic counseling in particular, to ensure that adult clients do understand eOlllplex
genetic intiJrmation and arc eomliJrtable conveying it to their 1~lIlli1y if they choose to do
so. !\Iong with a provincial education strategy, enhancing the undergraduate and
postgraduate medical school curricula to include further training in genetics may be a
desirable goal.
!?CCO/ll/llc/lllaliull #4: A second -~lcet of a provincial education strategy should
address public education in genetics, stal1ing with age appropriate inliJrlllation through
the school system(". This way, members of the public will have an opportunity to learn
about genetics early in life, allowing them to gradually develop 1~II11iliarity with genetic
care. This approach is likely to spark discussions (spontaneous as opposed to on demand)
about genetics with and among hlll1i1y members. This in turn may help overcome fears
oforhesitancy with availingofgeneticlare.
:;,3 Implications: Ceneral Context of Genetic Services Polic~' and Planning
This research points to several important and innovativedireetions tiJrtheoryand
methodology on knowledge translation with regard to genetic research. First. the
research results underscore the importan.~e of attending to the voices of li'ont-Iine service
providers. This group of key intlJrl11illlh, with the vantage points of proximity to end-
users and meta-level gaze of the system in gencral, cnablcs a perspective that is both
uniqueandvaluablc.
Second. thc research points to tlK need for attending to simple and cost-ciTecli\'e
changes to thc systcm as a means of improving service delivery and uptake. ror
example. the cumbersome nature of t~lJl1i1y history questionnaires elearly impacts post-
rcferral attrition ratcs in the province of Newl()llt1dland and Labrador. On this point. the
interview data raisc interesting question~; about whether and how restructuring
qucstionnaircs can facilitate both intra-familial communication and improvement or
client abilities to "stick with" genctic serviccs available to thcm. Further research on the
understanding and usc of l~lJnily history qucstionnaires is Ileeded. Locally, an analysis of
the effccts of introducing the improved \ersion of the family history questionnaire by the
PMGP could serve as a useful casc sludy to this end.
Third. the research raises intercsting questions about the "serviee-markcting vs.
lCar mongering" dilemma. Literature in thc tiekl of genetics has highlighted the problem
of"genetieization" and the "marketing of fcar"; thc literature has also emphasized
problems associated with the "knowlcdge delieit" about genetic inti:lrInation among the
lay public. Yet the relationship between the two phenomena (knowledgedelicit and
marketing of fcar) has not been adequatclyaddresscd. The interview data point to thc
nccd for research on the ccollomic and social implications of having a population that
secks out genetic testing services. Speci tieally. the data point to thc need Ill!' analysis of
the tension between the goals of public education about genetics, and the reality of scarce
resources toolkrgenctic services in a publicly funded health care system.
The study raised serious questions about whether and how insurance
discrimination results li'om genetic testing. Further research is clearly necded and, if
discrimination is indeed tound to be occ.lrring, it is important to introduce regulations
that prohibit genetic discrimination in Canada. While setting clear rules till' the insurance
industry. it will guarantee protection and will alle\'iate fcars of discrimination among
clients. It will also lessen hesitance among clinicians who may refrain Ii'om rdl.:rrals lilr
il.:arlheir patients may be discriminated .tgainst.
Participants only touched on sOlre cost issues related to the delivery of genetic
services. but their concern about cost clearly underscores the need (ill' eost-
dketiveness/cost-utility analyses. Those analyses should include nol only the cosls to the
hl:alth care system, but also personal ant' societal (non-hl:alth sector) linancial gains and
losses attributed to genetic services. Considering those hlctors will provide a valuable
perspective on thl: impaet that genetic sl:rviees have on clients. families. communities and
the province.
5.4 Study Limitations
Thereareanumberoflimitatiom;associated with this study and it ise.xpectcd that
future research will address them. A.lthough I conduetl:d interviews with a diverse r,lnge
ofgl:neticproil.:ssionals. nonethclessthedata is necessarily drawn fromarclalivclysmall
and homogeneous group of genetic professionals. Secondly. the genelie services I discuss
in this study are prm'ided li'om and within one system and are all part of the public health
systcm. Comparative work with vicws of gcnetic professionals in private settings or with
those cmployed in other provinces or countries may provide insights on the
(in)efticiencies of various types ofsystel11s and draw attention to similar or dissimilar
challenges. Another limitation is that al genetic prolcssionals who lit the recruitment
criteria were women. rcllccting the 1~let Ihat the majority of the genetic professionals in
the province are female. Subsequent research may highlight ditkrences betwecn male
and Il:male genetic practitioners' perspectives on barriers.
When interpreting the lindings o~'this study, caution should be applied to thc !~Ict
lhat the statements of the genetic prolcs5ionals are only snapshots in lime and ensuing
changes in their practice and the way they recruit. diagnose. counsel, !llilow up or treat
clienls are not rellected in this study. Regardless of those limitations there are lessons
learned about thc challenges in acccssing and availing of genctic services. Those lessons
can, and in fact should, be considered in designing an improved framework Ill!' the
delivery of genetic care within NL and morc broadly.
Research on patient's perspectives was intentionally not part of this study. as the
publishedresearchhasattendcdwelltothispcrspcctive. Within the local context.
howe\'er. research is stillnceded to juxtapose the data on pro\'iders' perspectives on
barriers to access-uptake of genetic services with those of the patients' themselves. in
order to inllJrlll service delivery in the province. The extent to II'hich the two points of
view arc consistcnt or divcrge will bc kcy inll)l'll1ation lor undcrstanding how to provide
soci~lIy and economic~lIy ~ppropriatc genetic services in a way that responds to the
inli'~struetural ~nd psychosocial ch~llen:~es 1~lced by those who choose to avail of genetic
5.5 Final Notes
This study contributes to the exi~;ting knowledge by providing an ~uthentic
~ccount of genetic professionals' perspectives on how the services they provide arc
org~nized, ~ceessed ~nd delivered ~nd what ~ccess-uptake ch~lIenges their clients 1~lce on
both systemic ~nd psychosocial levels. This rese~reh also contributes to our knowledge
~bout why certain individuals choose not to avail ofgenctic testing services, a
ch~lIenging perspective to ~ccess.
I\dequ~tely resourced ~nd better org~nized genetic care h~s the potential to
1~lcilitate appropriate ~eeess to and uptake of genetic service. The study provides a source
Il)r strategic direction to healthcare deci~.ion makers and he~lth policy m~kers regarding
short and long-term investments in gene:ic screening ~nd testing in this region and
beyond.
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APPENDICES
Appendix A
Invitation to Participate in Research Study
Dear XXX,
My name is Valerie Darmonkow. I am.] Master's student in the Division ofColllmunity
Health and Humanities, Memorial Univ,~rsity. I am conducting research on GCI/clic
I'ro!c'ssiol/a/s' Pcrspccli\'cs VI/ Burricrs IVlmrd .Icccss IV al/d Uplakc orGcl/Nic
SCITiccs. This study is pal1 of the Atlantic Medical Genetics and Gcnomics Initiative
[AMGGIl, (Terri-Lynn Young, PI). The AMGGI projcct involves a signiticant
qualitative research component, which seeks to understand the social, historical, cultural,
and economic barriers to access to and lise of genetic services from the perspecti\'cs of
patients, providers, and the public. My subproject involves individual interviews with 7-
12 genetic professionals.
As you arc a genetic professional working in the Atlantic region, I am inviting you to
participate in an interview that will take approximatcly 45 minutes to one hour. Your
professional experience, knowledge, and insights would be of great assistance in
understanding the barriers to access to and uptake ofgenctic services in our region.
To aid you in the process of deciding whether to participate, attached arc a sh0l1
dcscription of the study together with a COI/SCII/ /V 'l'akc ParI il/llca/III Rcscarch till"lll.
Contidentiality issues arc taken into consideration and thoroughly explained in item Xor
the timn. Should you choose to take part in this interview, please reply to this email, and
indicate:
(a) Possible dates and times ti)rthe interview over the next 6 weeks (sec attached
calendar)
(b) The location most convenient to you till' the interview
I would like to thank you Jill' laking time ti-om your busy schcdule and responding to this
invitation. I am!ooking tiJrlvard to heanng tj-OIll you.
Sincerely,
Valerie Danllonkow
MScin Medicine Candidate
Division ofColllmunity Health & Humanities
Faculty of Medicine
Memorial University of Newtoundland
Tel: (709) 754-87..tO or (709) 777-7284 (Dr. Fern Brunger, Supervisor)
Email: Illdarmonkow([lnfsympatico.GI
Appendix B
Consent Form
Faculty of i\ledicine, School of Nursing and Pharmacy of i\lemorial Universit~'of
Newfoundland; Eastern lIealth; I ewfoundland Cancer Treatment and Research
Foundation
Consent to Tak(' P.ut in Health Research
TITLE: Genetic Professionals' perspectives on barriers towards access and uptake of
genetic services
INVESTIGATOR(S): Valerie Darmonkow
SPONSOR: Genome I\tlantie
You have been invited to take part in a research study, It is up to you (0 decide whctherto
be in the study or noL Before you decide, you need to understand what the study is I()r,
what risks you might take and what bendits you might receive, This consent for explains
the study.
The researchers will:
- discuss the study with you
- answer your questions
- keep contidential any intllrmation which could identify you personally
- be a\'ailable during the study to dcalwith problems and answer questions
If you decide not to take part or to leave the study this \\'illnot afleet your relations with
researchers involved with the Atlantic i\ledical Genol1licandGcnctics Initiative.
I. Introduction/Background:
You arc being asked tu be interl'iewed about your perspective on barriers tu
aeec:ssand uptak:eot'gel1letie serlilees. This research will constitute a Master'suf
Science thesi:> and it part ofa broader research project un ethics and genetics
whiehailllstuunderstandtheslleial,historieal,euituralandeeonol1lieharriersto
access and usc of genetic servio:s. That project is itselfpartofa large-scale
science projeet, !\MGGI, funded by Genol1le Canada.
2. Purpose of study:
This research examines barriers to uptake of genetic services li"(Jm the
perspeeti\'es of genetic professionals working within Eastern Regional Integrated
Ilealth Authority of Newfoundland and Labrador. The objective of this research
is to identify and provide analysis of barriers towards access and uptake of
genetic services from the perspcctivesofgenetic professionals. The study will bc
based on qualitative interviews with 7-12 genetic professionals who provide
infiJrmation, counseling and support to bmiliesat risk. Three representative
genetic conditions. the locus of the broader AMGGI study, will be emphasized in
the qualitative inquiry: Arrhythrnogenie right ventricular cardiomyopathy
(ARVel. hereditary hearing impairment. and colorectal cancer.
3. Description of the study procedures and tests:
You will be interviewed by the investigator, Valerie Darmonkow. The interview
will take approximately one to one and a halfhoursand it will bcaud iotape-
recorded. You will be invited to describe and rellccton issues, concerns and
memories that you identify as important in understanding the barriers to access
and uptake of genetic services in the Atlantic region. In addition. you will be
invited to rctlcet on the ctkctiveness of genetic screening and testing.
You may refuse to answer and cuestion and can turn the tape-recorder oil or have
any portion of the tape dcleted if you wish. It~ liJllowing the interview, you lind
that you have additional infiJrll1ation to convey. or if you feel you may not ha\'e
expressed your belicts adequatcly during the interview, you may contact us to
havea fi>lIow-uptciephone interview scheduled at yourrequesl. You maybe re-
contacted alier the interview for clarification or further infiJrll1ation.
-I. Length of time:
Your interview will last approximately I Yo hours. It is possible that you will be
invited to participate in a tiJllo\\.-up interview iI'l require additional inliJrll1ation
or wish you to explain on point~, you have discussed.
5. Possible risks and discomliJrts:
Due to the small number and hi:~h prolile or genetic prolessionals in this region, I
cannot guarantee anonymity. If you choose to participate in this study you may
be at risk of having your identity inadvertently known by colleagues who read
publications arising from this research. This may lead to social harm to you.
should you be expressing point~ of view that may be at odds with the broader
community ofgeneties/genomics researchers and clinicians.
Ifany comments arc attributed to you as an identiliable individual in resulting
presentations/publications, you will h,I\'e prior opportunity to accept or reject that
attribution. As well. you will be given the opportunity to review publications and
aftirm or correct or correct any ,tatement that may be directly or indirectly
attributable to you. That is. any information to be used in publications that
rdlccts or quotes your perspective will be offered li)r review and approval by
you: and the inliJrlnation will be adjusted accordingly prior to publication.
You can choose whether or not you wish to be exp/icit/r ide/lli/ied as having
participated in this n.:seareh. At anytime you can reverse this decision.
Even if you choose to participate in this interview asan IIl1ideliti/iedsource of
intonnation, I cannot guarantee complete anonymity.
You will not be asked to disclo,.econtidential inliJrlnalion about yoursclfor your
clients. You can rcfuseto answcr any question and can requcstthat I turn the
tape-recorderollor have any portion ofthetapedclell;d.
6. Bene/its:
It is not known whether this stuJy will benetit you.
7. Liability Statement:
Signing this liJrln gives us your consent to be in this study. It tells us that you
understand the int(JrInation about the research study. When you sign this liJrln.
you do not give up your legal rights. Researchers or agencies involved in this
research study still have their legal and protCssional responsibilities.
X. Contidentiality:
You may choose whether or no!. to be identitied as ha\'ing participated in this
research; and at any time you can reverse your decision. To minimizc the risks of
misattribution or risks to reputation. when any comments arc attributed to you as
an identitiableindividual in rcsultingpresentations/publications. you will kl\'e
prior opportunity to accept. reject or correct that attribution.
Should you choose to participate in this interview as an unidentitiable source of
intiJrlnation. I will treat you as:;uch. However, dueto the small sizeofthe
interviewee community (geneti,: professionals working within Eastern Ilcalth of
NL). it is essential that you fully understand that in the process. there could bc a
potentiallossofeoniidentiality. Given that you, as a participant, may be
identiliable cvcnwith full precclutions about privacy and conlidentiality, you arc
asked 10 choose whether you wish to be explicitly identilied as having
partieipatedinthisreseareh.
Illlcrvi":lVlapcsalldtrallscriptslVillbcidclllili..:dbyllulllb..:r.alldlVillb..:a..:..:..:ssiblyollly
10th..:illl..:rviclVcr,h..:rsupcr\·isoralldtrallscriptiollisl(listcdbclow).Thcillt..:rvi..:wdala
ll1aybclls..:dill rlilurcsllldi..:s by Vakric Danllollkow or Dr, F..:rnl3rllllgcrilllh":ll..:xt
li\·cycars.lt will cOllslilUtcpal1 orlhcdata ILH·th..:broad..:r;\M(iCilprojccl.llll..:rvi..:w
data will b..:d..:stroycdalthc":lldorti\·cycars.
I'rallscriplswiIIIlOlCOlllaillidcllliryillgiIlILlI'Illalioll.;\codcllllll1bcrwillb..:assigll..:d.
,mdlhal illltll'lllaliollwillbcs..:cur..:lyslorni illalock..:d Iilillgc,lbill":lapan rroll1thc
Irallscriptsth":ll1sclvcs. ;\sw..:lI.ollcclhclapcistnlllscrib..:d.th..:illv..:stigatorwillhlll..:k
ollllr":ll1ovcallypolclltiallyid":1l1iryillgillltll'lllaliollcolltaillcdwithilltlwtC:Xlllrlh..:
Iralls..:npt
'J.<)lIcsliOIlS
Iryollhav..:allyqll..:stiollsaboutlakillgparl ill this sllldy. yOllC,11l Illccl wilhth..:
illvcstigatorlVho is ill..:harg":Orlhcsllldyal this illslillilillll.Thal pcrsoll is'
Vakri..: l)arJlllJllkow: (70'J)75L 87-+0 or Illdanllollkow(lI ilLs 1l11atiw.ca
;\lso.iryollhav..:allyqu,,:slillllsabllllllhcsllldyorwaIllILlrthcrilllLlI'IllatiollYllucall
cOlllactl)r. F..:rnI3rullg..:r(sllpcrvimr.co-illv..:stigaloroll(il:'LScolllpoll":llt)alth..:
FacllllyorNkdicillc.M":ll1orial Uri\usity.aI777-728.../orlbrllllg":1'(1I'1ll1l1l.ca
Or.yollcalllalklosOIl1":llll..:whoisIlOlill\'()!v..:dilllhcsllldyalall.b1I1..:alla(h'is":YOllOIl
yourrightsasapanicipallt illar..:s:archstlldy.Thispcrsollcallbcrcachcdlhrollgh:
OfliccllrtheII1lIl1alllllvcstl!!,lIiOIlColl1llliIlCc(IIIC)al(7()'J)777-6'J7...
Dllail:hic(lIll1ull.ca
Signature Page
Study Titlc: Gcnctic Pr'ofcssionals' pcrspcctivcs on barricrs towards acccss and uptakc of
:,:cucticscl'viccs.
Namcofprincipalinvcstigator: ValcricDarmonkow
To bc fillcd out and signcd bythc participant:
I'lcascchcckas appropriatc:
I havcrcildlhcconscnt[illldinforlllationsh,:ct]
IhavclHldlhcopporlunityto,lskqucstions/todiscussthisSIUdy
I havc rcccinxi satisl;lctoryanswcrstoall oflllyqucstions.
Ihavcrcccivcdcnoughinforillationaboutthcstudy.
I havcspokcn 10 Valcric Darnlllnkowand S:lchas
illlswcrcdalllllyqucstions.
lundcrstandthatlallll'rcctowithdrawfrol'llhcstudy
-atilllytllllc
-withouthavingtogivcarcason
I undcrstandthat it iSlllychoicctobcinthcstudyand
thatllllaynotbcnclit.
I agrcc to bcaudio-tilpcd.
lagrcctowkcpiu1inthcstudy.
Signaturcofl'articipanl Dak
SignaturcofWitncss
Tohcsioncdhvthcinvcslioator:
Yes: : I tl: :
Yes: : No: :
Yes: : Ntl: :
Yes: : Ntl: :
Yes: : No: :
Yes: : No: :
Yes: : No: :
Yes:: No: :
Yes: : No: :
Ihavccxplaincdihisstudytothcbcstoflllvability.linvitcdqucstionsandgavcanswcrs.1
hclicvcthatthcparticipantfullyundcrstandswhatisinvolvcdinbcinginthcstudy.ilnypotcntial
risksoflhcstudyandthathcorshchasfrn:lychoscntobcinthcstudy
Signaturcoflnvcstigator Datc
rclcphoncnulllbcr: _
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Appendix C
Irlte.-viewCuide
Section A: Introduction
• Th;Jnk you lor agreeing t,) p;Jrticipate in the study. Icc breaker.
• Oller to review study int;lrmation: I hope you h;Jve read the information
ahout this study that wus sent out to you.
• Provide opportunity to ask questions: Do you have any questions about the
research')
• Brief interviewee about cthics/conlidentiality and review consent I(mn:
obtain verbal answers tOlhesignature page; interviewee signs the consent
1·(Jr111 (Those interviewed via phone have already returlled the consent Il>rlll
via l~lX prior to the interview).
Section B: Baelq.\round information
• I understand that you are working as a genetic professional within the
Provincial Medical Genetie Program. Tell me something about the
Program.
• Please describe the nature of your work. What rolesandresponsibi litiesdo
you have') Ilow long ha\'~ you been practicing') What arc the qualilication
requirements tor your role')
• In approximate terms. how many adult clients do you sec at the clinic ina
courseot'oneye;Jr'l
• Please explain where your clients reside') Arc they all from St. John's'l
Section C: Specific experiences re~~ardingvarious aspects of service delivery
• Would you please discus:; the way individuals are rclcrred to thecl inic')
• Ilow eflicient is this mechanism') What could be improved'!
• Would you please describe what guidclinesand protocols arc 1()lIll1ved in
the clinic')
• Please provide a sense of how long the wait times tllr gendie sen'iees arc.
What arc the issues')
• According to you. what l'hallenges, ifany, do genetic professionals
encounter in serving theil' clients') Tell me about strategies you apply (or
you arc aware (1) Illr oVlTcoming these constraints.
Scction D: Pcrccptions about c1icnts
• What do your clients knc,wabout genetic services'!
• Where do your clients obtain information about genetics and genctic
diseases'!
• What arc your clients' attitudes toward genetic services')
• Please help me understand what concerns or fears, ifany. clients have
regarding genetics and g.:netie testing. Tell me about strategies you apply
(or you arc aware ot) Illr overcoming these constraints.
• What other challenges do your clients experience in pursuing genetic care'!
Scction E: Wrap- p and Closing
• I wonder whether, based on your observations or experiences, you would
like to share any additional thoughts or provide further comments
regarding barriers to acct:ss-uptake of genetic services.
• Thank you.
• Mention about possible post-interview contact (note ifin agreement): In
case further clarification is needed. I hope you do not mind if I contact
you. Likewise, if you want to share additional thoughts that may come up
with alter the interview, you arc welcome to contact me.
• Dc-brief.




